Настройки

Укажите год
-

Небесная энциклопедия

Космические корабли и станции, автоматические КА и методы их проектирования, бортовые комплексы управления, системы и средства жизнеобеспечения, особенности технологии производства ракетно-космических систем

Подробнее
-

Мониторинг СМИ

Мониторинг СМИ и социальных сетей. Сканирование интернета, новостных сайтов, специализированных контентных площадок на базе мессенджеров. Гибкие настройки фильтров и первоначальных источников.

Подробнее

Форма поиска

Поддерживает ввод нескольких поисковых фраз (по одной на строку). При поиске обеспечивает поддержку морфологии русского и английского языка
Ведите корректный номера.
Ведите корректный номера.
Ведите корректный номера.
Ведите корректный номера.
Укажите год
Укажите год

Применить Всего найдено 1700. Отображено 199.
27-10-2007 дата публикации

АЗАГЕТЕРОЦИКЛЫ, КОМБИНАТОРНАЯ БИБЛИОТЕКА, ФОКУСИРОВАННАЯ БИБЛИОТЕКА, ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ И СПОСОБЫ ИХ ПОЛУЧЕНИЯ

Номер: RU2006111951A
Принадлежит:

... 1. Азагетероциклы общей формулы 1 где R1a представляет собой заместитель аминогруппы; Rb и Rc вместе с атомом углерода, с которым они связаны, образуют карбонильную группу, атом углерода которой находится в цикле; R1d и R2d вместе с атомом углерода, с которым они связаны, образуют карбонильную группу, атом углерода которой находится в цикле; Х представляет собой группу NR2a, атом азота которой находится в цикле, a R2aпредставляет собой заместитель аминогруппы; W, Y и Z вместе образуют метиленовую группу CR3dR4d, в которой R3d и R4d, независимо друг от друга, представляют собой заместитель циклической системы или R3d и R4d вместе с атомом углерода, с которым они связаны, образуют через R3d и R4d циклоалкил или гетероциклил; или R2a, вместе с атомом азота с которым он связан, и R3d, вместе с атомом углерода, с которым он связан, замыкают через R2aи R3d азагетероцикл; или где R1a представляет собой заместитель аминогруппы; Rb представляют собой карбамоильную группу; Rc представляют собой заместитель ...

Подробнее
26-07-1972 дата публикации

METHOD OF PREPARATION OF MACROCYCLIC COMPOUNDS

Номер: GB0001283296A
Автор:
Принадлежит:

... 1283296 Macrocyclic compounds RESEARCH CORP 18 March 1970 [17 July 1969] 12935/70 Addition to 1185936 Heading C2C [Also in Division C5] Macrocyclic hydrocarbons or lactones of up to 20 carbon atoms are prepared by heating a solution of a cyclic ketone di- or tri-peroxide, the ketones being characterized by the presence of a 5-member or larger ring, in an organic hydrocarbon solvent to a temperature sufficiently high to cause decomposition of the said peroxides. Dilactones may be produced from triperoxides and monolactones are produced from di- or tri-peroxides.

Подробнее
21-12-1994 дата публикации

Fluid chemical biocide

Номер: GB0009422202D0
Автор:
Принадлежит:

Подробнее
15-05-1993 дата публикации

chemiluminescent 3-(substituted adamant-2'-ylidene) 1,2-dioxetanes

Номер: OA0000009659A
Принадлежит:

Подробнее
15-03-1996 дата публикации

CHEMILIMINESZENTE 1,2-DIOXETAN-VERBINDUNGEN

Номер: AT0000135353T
Принадлежит:

Подробнее
10-07-1974 дата публикации

Procedure for the production of a mixture from macrocyclischen hydrocarbons and Lactonen apart from small quantities of Dilactonen

Номер: AT0000316505B
Автор:
Принадлежит:

Подробнее
23-02-1995 дата публикации

Chemiluminescent 3-(substituted adamant-2'-ylidene) 1,2-dioxetanes

Номер: AU0000656927B2
Принадлежит:

Подробнее
01-12-1977 дата публикации

PROSTAGLANDIN-TYPE 1,15-LACTONES

Номер: AU0001428876A
Принадлежит:

Подробнее
19-03-1991 дата публикации

PROCESS FOR THE PRODUCTION OF MACROCYCLIC ESTERS BY THE DEPOLYMERIZATION OF POLYESTERS

Номер: CA0001281726C

The catalytic thermal depolymerization of polyesters to produce macrocyclic esters suitable for fragrance applications is carried out using an olefin polymer. High yields of the corresponding macrocyclic ester are produced at high rates while substantially eliminating reactor fouling and the formation of undesirable by-products. The depolymerization is most advantageously conducted using polyethylene.

Подробнее
06-10-1998 дата публикации

METHODS OF USING CHEMILUMINESCENT 1,2-DIOXETANES

Номер: CA0001340070C
Принадлежит: TROPIX INC, TROPIX, INC.

Processes are disclosed in which light of different wavelengths is simultaneously released from two or more enzymatically decomposable chemiluminescent 1,2-dioxetane compounds, said compounds being configured, by means of the inclusion of a different light emitting fluorophore in each of them, to each emit light of said different wavelengths, by decomposing each of said compounds by means of a different enzyme. Such processes can be used in multi-channel assays --immunoassays, chemical assays and nucleic acid probe assays -- to detect the presence or determine the concentration of chemical or biological substances, and in multi-channel chemical/physical probe procedures for studying the microstructures of macromolecules.

Подробнее
12-08-1999 дата публикации

NOVEL ANTIFUNGAL COMPOUNDS AND PROCESS FOR PRODUCING THE SAME

Номер: CA0002319807A1
Принадлежит:

Compounds represented by general formula (I) which have potent antifungal activity without showing any chemical injury to man, beast or agricultural/horticultural plants to which the compounds are to be applied and show high photostability, wherein R1 represents isobutyryl, tigloyl, isovaleryl or 2-methylbutanoyl; R2 represents hydrogen, aromatic carboxylate or an amino-protective group; and R3 represents hydrogen, nitro, amino, acylamino or N,N-dialkylamino (provided that the case where R1 is isobutyryl, tigloyl, isovaleryl or 2-methylbutanoyl and R3 is hydrogen, and then R2 is 3- hydroxypicolinate, 3-hydroxy-4-methoxypicolinate or 3,4-dimethoxypicolinate is excluded).

Подробнее
30-08-2012 дата публикации

CHRYSOPHAENTIN ANALOGS THAT INHIBIT FTSZ PROTEIN

Номер: CA0002828360A1
Принадлежит:

Embodiments of antimicrobial chrysophaentin compounds, pharmaceutical compositions including the chrysophaentin compounds, methods for using the chrysophaentin compounds, and methods for synthesizing the chrysophaentin compounds are disclosed. Certain embodiments of the chrysophaentin compounds inhibit FtsZ protein, thereby inhibiting the growth of clinically relevant bacteria, including drug-resistant strains.

Подробнее
18-12-2001 дата публикации

SYNTHESIS OF STABLE WATER-SOLUBLE CHEMILUMINESCENT 1,2-DIOXETANES AND INTERMEDIATES THEREFOR

Номер: CA0002035029C
Принадлежит: Tropix, Inc., TROPIX INC, TROPIX, INC.

A novel synthesis of compounds having the formula: (See formula I) wherein T is a stabilizing spiro-linked polycycloalkyli- dene group, R3 is a C1-C20 alkyl, aralkyl or heteroatom containing group, Y is an aromatic fluorescent chromo- phore, and Z is a cleavable group which, when cleaved, induces decomposition of the dioxetane ring and emission of optically detectable light, is disclosed. A tertiary phosphorous acid alkyl ester of the formula: (R1O)3P wherein R1 is a lower alkyl group, is reacted with an aryl dialkyl acetal produced by reacting a corresponding aryl aldehyde with an alcohol of the formula: R30H wherein R3 is as defined above, to produce a 1-alkoxy-1- aryl-methane phosphonate ester of the formula: (See formula II) ...

Подробнее
18-07-2000 дата публикации

CHEMILUMINESCENT 3-(SUBSTITUTED ADAMANT-2'-YLIDENE) 1,2-DIOXETANES

Номер: CA0002069957C
Принадлежит: Tropix, Inc.

Enzymatically cleavable chemiluminescent 1,2-dioxetane compounds capable of producing light energy when decomposed, substantially stable at room temperature before a bond by which an enzymatically cleavable labile subsituent thereof is intentionally cleaved, are disclosed. These compounds can he represented by formula (I) wherein X and X1 each represent. individually, hydrogen, a hydroxyl group, a halo substituent, an unsubstituted lower alkyl group, a hydroxy (lower) alkyl group, a halo (lower) alkyl group, a phenyl group, a halophenyl group, an alkoxyphenyl group, a hydroxyalkoxy group. a cyano group, a carboxyl or substituted carboxyl group or an amide group, with at least one of X and X1 being other than hydrogen; and R1 and R2 individually or together, represent an organic substituent that does not interfere with the production of light when the dioxetane compound is enzymatically cleaved and that satisfies the valence of the dioxetane compound's 4-carbon atom, with the provisos that ...

Подробнее
01-03-1992 дата публикации

CHEMILUMINESCENT 3-(SUBSTITUTED ADAMANT-2'-YLIDENE) 1,2-DIOXETANES

Номер: CA0002069957A1
Принадлежит:

Подробнее
07-11-1996 дата публикации

FATTY ACID ESTERS AS BIOACTIVE COMPOUNDS

Номер: CA0002218702A1
Принадлежит:

Compounds of structure (I), and when for use in therapy: where R1 is an acyl group derived from a C16-30 fatty acid with two or more cis or trans double bonds and particularly an n-6 or n-3 series EFA or conjugated linoleic acid, or columbinic acid, or parinaric acid and R2 is as R1 the same or different, or any other nutrient, drug or other bioactive residue released as the active in the body and R3 is either hydrogen, fully hydrocarbon, or containing heteroatoms, preferably an alkyl group particularly a C1-C4 alkyl group.

Подробнее
09-01-1997 дата публикации

PROCESS FOR THE PREPARATION OF 1,2-DIOXETANE COMPOUNDS AND NOVEL SULFUR-SUBSTITUTED 1,2-DIOXETANE COMPOUNDS AS INTERMEDIATES

Номер: CA0002223293A1
Принадлежит:

A process is provided for the preparation of a variety of triggerable dioxetanes bearing alkoxy, alkenyloxy, alkynyloxy, arlyoxy, aralkyloxy or acyloxy substituents from a common intermediate along with sulfur-substituted dioxetanes and vinyl sulfide compounds used as intermediates. Alkoxy, alkenyloxy, alkynyloxy, arlyoxy, aralkyloxy or acyloxy substituted dioxetanes are useful in detecting activating agents and in assays such as immunoassays and nucleic acid hybridization assays. The sulfur-substituted dioxetanes additionally are useful for producing chemiluminescence. The novel process involves conversion of a vinyl sulfide compound to a sulfur-substituted dioxetane, reacting the sulfur-substituted dioxetane with an electrophilic agent and a hydroxylic compound or salt thereof and forming the alkoxy, alkenyloxy, alkynyloxy, arlyoxy, aralkyloxy or acyloxy-substituted dioxetane.

Подробнее
14-05-1998 дата публикации

WATER SOLUBLE TRI-SUBSTITUTED 1,2-DIOXETANE COMPOUNDS HAVING INCREASED STORAGE STABILITY, SYNTHETIC PROCESSES AND INTERMEDIATES

Номер: CA0002238365A1
Принадлежит:

Stable, enzymatically triggered chemiluminescent 1,2-dioxetanes with improved water solubility and storage stability are provided as well as synthetic processes and intermediates used in their preparation. Dioxetanes further substituted with two or more water-solubilizing groups disposed on the dioxetane structure and an additional fluorine atom or lower alkyl group provide superior performance by eliminating the problem of reagent carryover when used in assays performed on capsule chemistry analytical systems. These dioxetanes display substantially improved stability on storage. Compositions comprising these dioxetanes, a non-polymeric cationic surfactant enhancer and optionally a fluorescer, for providing enhanced chemiluminescence are also provided.

Подробнее
29-10-1998 дата публикации

SELECTIVE OLEFIN METATHESIS OF BIFUNCTIONAL OR POLYFUNCTIONAL SUBSTRATES IN COMPRESSED CARBON DIOXIDE AS REACTION MEDIUM

Номер: CA0002286610A1
Принадлежит:

Cyclic products are prepared by selective olefin metathesis of bifunctional or polyfunctional substrates in the presence of one or several homogeneous or heterogeneous metathesis catalysts in a reaction medium. The invention is characterised in that the substrates contain two or more functional groups in the form of substituted or non-substituted alkene or alkyne units and in that the reaction medium essentially consists of compressed carbon dioxide. Also disclosed is the preparation of cyclic or polymer products according to the disclosed process, the reaction temperature and total pressure being matched to ensure that the density of the reaction medium lies in a range d = 0.2-1.5 g/cm-3 and that the product distribution is essentially controlled by the reaction medium density.

Подробнее
15-12-1982 дата публикации

PROCEDURE FOR THE PRODUCTION OF NEW THROMBOXAN ANALOGUES.

Номер: CH0000633551A5
Автор: ROBERT CHARLES KELLY
Принадлежит: UPJOHN CO, UPJOHN CO.

Подробнее
30-09-1982 дата публикации

PROCEDURE FOR THE PRODUCTION OF CYCLI ESTERS AND CAN DISA YOUR.

Номер: CH0000632264A5

Подробнее
14-08-1981 дата публикации

Process for the preparation of prostaglandin-like 1,15-lactones

Номер: CH0000624679A5
Принадлежит: UPJOHN CO, UPJOHN CO.

Prostaglandin-like 1,15-lactones of the formula in which the substituents are defined in Claim 1, are prepared. These compounds are obtained by lactonisation of corresponding prostaglandin-like compounds of the formula in which M1 is defined in Claim 1. Reduction of lactones with a 9-keto group in the cyclopentane ring results in corresponding 9 alpha - or 9 beta -hydroxyl compounds. The resulting lactones have prostaglandin-like properties and can be used for the same purposes as prostaglandins.

Подробнее
31-08-1981 дата публикации

Process for the preparation of prostaglandin-like 1,9-lactones

Номер: CH0000624950A5
Принадлежит: UPJOHN CO, UPJOHN CO.

Prostglandin-like 1,9-lactones of the formula or in which the substituents are defined in Claim 1, are prepared. These compounds are obtained by lactonisation of corresponding prostaglandin analogues which are in the form of free acids. Lactones which have a hydroxyl group in position 11 are oxidised to the corresponding 11-keto compounds. The resulting lactones have prostaglandin-like properties and can be used for the same purposes as prostaglandins.

Подробнее
15-07-1977 дата публикации

Dilactones of dioxabicycloalkanes - prepd. from corresp. dioxabicycloalkene by photo oxygenation then treatment with Lewis acid,for use in perfumery

Номер: CH0000589642A5
Автор:
Принадлежит: FIRMENICH & CIE, FIRMENICH SA

Prepn. of a dilactone cpd. of formula (I) below: in which n is 4-16, comprises oxidising a cpd. of formula (II) above with oxygen in the singet state (see. e.g. C.S. Foote, Accounts of Chem. Research, 1, 1968) and then treating the osidn. prod. with a Lewis acid. (II) in which n = 10, i.e. 13,16-dioxabicyclo 14.4.0 -hexadec-1-(12)-ene, is novel. The dilactones are used as perfumes. The process has the advantage of being better industrially than previous processes. Also cpd. (II) in which n = 10 can easily be obtd. from cyclododecanone, a low priced readily available cpd. In an example, 2,5-dioxahexadeca-1,6-dione is obtd. by photooxidation of cpd. (II) in which n = 2, using oxygen; the starting material is obtd. by halogenating cyclododecanone to the alpha-Br cpd. which is reacted with ethylene glycol to form the alpha-PCH2CH2OH cpd. which is then cyclised.

Подробнее
15-03-1983 дата публикации

METHOD FOR PRODUCING HETERO-MACROCYCLIC.

Номер: CH0000635094A5
Принадлежит: EMERY INDUSTRIES INC, EMERY INDUSTRIES, INC.

Подробнее
14-07-1978 дата публикации

Номер: CH0000601283A5

Подробнее
31-08-1981 дата публикации

Process for the preparation of prostaglandin-like 1,11-lactones

Номер: CH0000624951A5
Принадлежит: UPJOHN CO, UPJOHN CO.

Prostaglandin-like 1,11-lactones of the formulae in which the substituents are defined in Claim 1, are prepared. These lactones are obtained by lactonisation of corresponding prostaglandin-like hydroxy carboxylic acids and subsequently removing protective groups which are present. The prepared lactones have prostaglandin-like effects and can be used for the same purposes as the corresponding free acids.

Подробнее
14-02-1986 дата публикации

Process for the preparation of macrocyclic ester compounds

Номер: CH0000654304A5

Macrocyclic ester compounds of the general formula III in which R and R' in each case denote hydrogen or one of the radicals R or R' denotes hydrogen and the other radical denotes methyl or ethyl and l is a positive integer from 6 to 14. These compounds are obtained by adding a glycol and/or oligoester compound of the formula in which m is an integer and is 0 to 20 and R'' denotes a hydroxy group or a group of the formula in which R''' is H or C1-C3-alkyl, to a reaction system which contains a linear ester compound with repeating units of the formula The macrocyclic esters obtained can be used as a musk perfume.

Подробнее
31-01-1986 дата публикации

PREPARATION OF CARBONATES OF ALKENES.

Номер: CH0000653984A5

Подробнее
12-03-2008 дата публикации

Novel materials for organic electroluminescent devices

Номер: CN0101142294A
Принадлежит:

Подробнее
24-05-2002 дата публикации

Chiral diphosphine compounds used for producing metallic diphosphine complexes used as catalysts in asymmetric hydrogenation processes

Номер: FR0002816946A1
Принадлежит:

La présente invention à pour objet de nouvelles diphosphines chirales (R) ou (S), et leur utilisation comme ligand optiquement actif pour la préparation de complexes diphosphino-métalliques. L'invention concerne aussi les complexes diphosphino-métalliques comprenant lesdites diphosphines chirales (R) ou (S), ainsi que l'utilisation desdits complexes diphosphino-métalliques comme catalyseur dans des procédés de catalyse asymétrique de composés insaturés porteurs de groupements fonctionnels.

Подробнее
16-10-2009 дата публикации

BIOMARQUEUR HAS LUMINESCENT EMISSION

Номер: FR0002886292B1
Принадлежит: QUIDD, UNIVERSITE DE ROUEN

Подробнее
01-12-2006 дата публикации

BIOMARQUEUR HAS LUMINESCENT EMISSION

Номер: FR0002886292A1
Принадлежит:

La présente invention se rapporte à de nouveaux dérivés du 1,2-dioxétane de formule générale définie, aptes à émettre un signal luminescent détectable, à leur utilisation dans un procédé de détection et/ou de quantification d'un phénomène physique, chimique ou biologique, notamment enzymatique, ainsi qu'à un kit permettant la mise en oeuvre du procédé.

Подробнее
21-01-1977 дата публикации

NOVEL PHARMACEUTICAL COMPOSITION BASED ON A LACTONE PROSTAGLANDIN

Номер: FR0002315266A1
Автор:
Принадлежит:

Подробнее
21-01-1977 дата публикации

NEW 1,9-LACTONE TYPE PROSTAGLANDIN, METHOD FOR ITS PREPARATION AND MEDICAMENT CONTAINING THE

Номер: FR0002315267A1
Автор:
Принадлежит:

Подробнее
19-10-1979 дата публикации

CYCLOPOLYFORMALDEHYDES ET LEUR PROCEDE DE PREPARATION

Номер: FR0002420533A
Автор: ALLAN STUART HAY
Принадлежит:

Cyclopolyformaldéhydes ayant pour formule : ...

Подробнее
16-06-1978 дата публикации

ANALOGUES DE THROMBOXANE

Номер: FR0002371441A
Автор:
Принадлежит:

La présente invention se situe dans le domaine des analogues de thromboxane. Elle concerne des composés répondant par exemple à la formule suivante : ...

Подробнее
30-08-2012 дата публикации

CHRYSOPHAENTIN ANALOGS THAT INHIBIT FTSZ PROTEIN

Номер: WO2012116254A2
Принадлежит:

Embodiments of antimicrobial chrysophaentin compounds, pharmaceutical compositions including the chrysophaentin compounds, methods for using the chrysophaentin compounds, and methods for synthesizing the chrysophaentin compounds are disclosed. Certain embodiments of the chrysophaentin compounds inhibit FtsZ protein, thereby inhibiting the growth of clinically relevant bacteria, including drug-resistant strains.

Подробнее
01-09-2011 дата публикации

CHRYSOPHAENTIN ANTIMICROBIAL COMPOUNDS THAT INHIBIT FTSZ PROTEIN

Номер: WO2011106630A3
Принадлежит:

Embodiments of antimicrobial chrysophaentin compounds, pharmaceutical compositions including the chrysophaentin compounds, and methods for using the chrysophaentin compounds are disclosed. Some embodiments of the disclosed compounds are isolated from Chrysophaeum taylori. Certain embodiments of the chrysophaentin compounds inhibit FtsZ protein, thereby inhibiting the growth of clinically relevant bacteria, including drug-resistant strains.

Подробнее
14-07-2005 дата публикации

CATALYTIC SULFOXIDE-PROMOTED C-H OXIDATION, AND REGIOSELECTIVE PREPARATION OF ALLYLIC CARBOXYLATES

Номер: WO2005062811A2
Принадлежит:

One aspect of the present invention relates to a method of preparing allylic carboxylate compounds comprising the step of contacting a compound comprising an allylic hydrogen atom with a carboxylic acid in the presence of palladium, a sulfoxide compound, and an oxidant. For example, the instant invention provides a catalytic method for the direct C-H oxidation of monosubstituted olefins to prepare linear (E)-allylic acetates in high regio- and stereoselectivities. In addition, the method of the instant invention can be used to prepare branched allylic carboxylates with high yield and regioselectivity. Another aspect of the present invention relates to sulfoxide compounds that are useful as catalysts to effect C-H oxidation. Remarkably, the allylic oxidation method of the invention is compatible with a wide range of functionality, such as amides, carbamates, carbonates, esters, and ethers.

Подробнее
21-10-1999 дата публикации

PROCESS FOR PRODUCING HYDROXYLACTONE COMPOUND

Номер: WO1999052891A1
Принадлежит:

A process for industrially producing a ketone compound for use as a catalyst in the production of an optically active phenylglycidic acid derivative and for producing a hydroxylactone compound as a precursor for the ketone compound, which comprises subjecting an epoxy compound (I) or a salt thereof to intramolecular ring closure to produce the hydroxylactone compound (II) or a salt thereof and oxidizing this compound (II) to obtain the corresponding ketone compound. (In the formulae, ring Ar is an optionally substituted mono- to tricyclic aromatic ring; Alk is a single bond or optionally substituted alkylene; Q is CO or SO2; X is O or S; and R1 is H or lower alkyl).

Подробнее
26-09-2000 дата публикации

Methods of using 1,2-dioxetanes and kits therefore

Номер: US0006124478A1
Принадлежит: TROPIX, INC.

Compounds having the formula: ##STR1## wherein T is a polycycloalkylidene group (e.g., adamant-2-ylidene); R is a C.sub.1-20 alkyl, aralkyl or cycloalkyl group; and Y is a fluorescent chromophore (e.g., m-phenylene), produced by reacting a compound having the formula: ##STR2## with an R-ylating agent (e.g., R.sub.2 SO.sub.4) in the presence of an alkali metal alkoxide in a polar aprotic solvent. Also, compounds having the formula: ##STR3## are produced by reacting a compound having the formula: ##STR4## with ##STR5## wherein X is an electronegative leaving group (e.g., a halogen anion such as chloride ion) in the presence of a Lewis base (e.g., a trialkyl-amine) dissolved in an aprotic organic solvent (e.g., benzene or toluene). Also, compounds having the formula ##STR6## are produced by reacting a compound of the formula ##STR7## with a tetra-O-acylated-O-hexopyranoside halide, then hydrolyzing off the protective acyl groups. The aforementioned compounds and procedures are useful in the ...

Подробнее
20-05-1997 дата публикации

Alkene adamantane intermediates and the corresponding 1,2-dioxetanes

Номер: US0005631353A1

Alkene adamantane compounds useful as intermediates for producing the corresponding 1,2-dioxetanes which are useful in chemiluminescent assays.

Подробнее
10-08-1999 дата публикации

Process for the preparation of 1,2-dioxetane compounds and novel sulfur-substituted 1,2-dioxetane compounds as intermediates

Номер: US0005936101A1
Принадлежит: Lumigen, Inc.

A process for producing a stable triggerable dioxetane comprising; (a) reacting a vinyl sulfide compound containing a sulfur-substituent SR4, wherein R4 is an organic group containing 1 to 20 carbon atoms and optionally heteroatoms, with oxygen and light in the presence of a photosensitizer to form an intermediate sulfur-substituted dioxetane compound; and (b) reacting the sulfur-substituted dioxetane compound with an electrophilic compound E--Y and a hydroxylic compound R5 OH selected from the group consisting of alcohols, phenols and carboxylic acids or their salts and containing an OR5 group to replace the SR4 group of the dioxetane with the OR5 group.

Подробнее
09-02-1999 дата публикации

1,2-dioxetane compounds as chemiluminescent labels for organic and biological molecules

Номер: US0005869698A1

Dioxetanes which couple with organic and biological molecules of the formula: см. иллюстрацию в PDF-документе wherein X is a leaving group which is removed by an `activating agent to produce light, wherein A is a coupling substituent, Ar is a substituent selected from the group consisting of phenyl and naphthyl to provide a label are described. R1 is an optional linker substituent and can have between 1 and 30 carbon atoms with some of the carbon atoms being oxygen, sulfur, nitrogen or phosphorus. Ar as phenyl is preferred. The dioxetane coupled molecules are useful in assays of all types where luminescence can be used as an indicator.

Подробнее
08-07-1997 дата публикации

Process for controlled depolymerization of feed material to produce a product with lower molecular weight

Номер: US0005646306A1
Принадлежит: Henkel Corporation

The practicality of known depolymerization reactions in which there is a danger of building up adherent residues on heat transfer surfaces is greatly improved by performing the process under conditions that provide a driving force which assures that none of the feed material and none of any liquid or solid residue produced during the depolymerization of the feed material remains in contact with any heat transfer surface for a time sufficiently long to form any adherent solid residue on the surface. A preferred apparatus for achieving such a driving force includes a horizontal thin film evaporator, a controlled continuous input of liquid feed material, and continuous collection of desired reaction product and any residue that remains condensed throughout its passage through the reaction zone. The process is especially well adapted to producing cyclic ethylene tridecanedioate, cyclic ethylene dodecanedioate, and cyclopentadecanolide from higher molecular weight feed materials such as linear ...

Подробнее
16-12-1980 дата публикации

Antibiotics produced by Cytospora sp. W.F.P.L. 13A

Номер: US0004239690A1

When Cytospora sp. is subjected to aerobic fermentation a number of new antibiotics are produced. Methods of production, recovery and purification of these antibiotics are described and some of their antimicrobial properties are described. One of the new antibiotics discovered (Grahamimycin A) corresponds to the formula: см. иллюстрацию в PDF-документе Another (Grahamimycin B) corresponds to the formula: см. иллюстрацию в PDF-документе ...

Подробнее
27-11-2001 дата публикации

Kit for conducting an assay to detect a substance using enzymatically-induced decomposition of dioxetanes

Номер: US0006322727B1
Принадлежит: Tropix, Inc., TROPIX INC, TROPIX, INC.

A kit for detecting a first substance in a sample including a stabilized 1,2-dioxetane bearing an enzyme-labile substituent, which is destabilized and caused to decompose by contacting the 1,2-dioxetane with an enzyme under conditions which cause the enzyme to cleave the enzyme-labile group from the dioxetane, thereby yielding a negatively charged oxygen anion bonded to the 1,2-dioxetane, which causes the 1,2-dioxetane to decompose without input from an external excitation energy source, the decomposition being accompanied by chemiluminescence; and a second component selected from the group consisting of a specific affinity substance (e.g., an antigen, an antibody or a nucleic acid probe) and an enzyme which destabilizes said 1,2-dioxetane.

Подробнее
20-05-1997 дата публикации

Alkene adamantane intermediates and the corresponding 1,2-dioxetanes

Номер: US0005631353A
Автор:
Принадлежит:

Alkene adamantane compounds useful as intermediates for producing the corresponding 1,2-dioxetanes which are useful in chemiluminescent assays.

Подробнее
16-03-2010 дата публикации

Macrocyclic tertiary amine beta-secretase inhibitors for the treatment of alzheimer's disease

Номер: US0007678783B2

The present invention is directed to macrocyclic tertiary amine compounds represented by general formula (I) which are inhibitors of the beta-secretase enzyme and that are useful in the treatment of diseases in which the beta-secretase enzyme is involved, such as Alzheimer's disease. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the treatment of such diseases in which the beta-secretase enzyme is involved.

Подробнее
29-11-2016 дата публикации

Treprostinil derivative compounds and methods of using same

Номер: US0009505737B2

Compounds represented by formulae I, II, III, and IV including pro-drugs for treprostinil and prostacyclin analogs. Uses include treatment of pulmonary hypertension (PH) or pulmonary arterial hypertension (PAH). The structures of the compounds can be adapted to the particular application for a suitable treatment dosage. Transdermal applications can be used.

Подробнее
06-02-2008 дата публикации

LIGHT-EMITTING BIOMARKER

Номер: EP0001883635A2
Принадлежит:

Подробнее
02-01-2013 дата публикации

CHRYSOPHAENTIN ANTIMICROBIAL COMPOUNDS THAT INHIBIT FTSZ PROTEIN

Номер: EP2539305A2
Принадлежит:

Подробнее
05-12-1990 дата публикации

Chemiluminescent doubletriggered 1,2-dioxetanes

Номер: EP0000401001A3
Принадлежит:

Подробнее
10-08-1994 дата публикации

DIOXETANES FOR USE IN ASSAYS

Номер: EP0000348494B1
Принадлежит: TROPIX, INC.

Подробнее
21-01-2009 дата публикации

Номер: JP0004213205B2
Автор:
Принадлежит:

Подробнее
10-06-2008 дата публикации

СПОСОБ НУКЛЕАЦИИ ПОЛИОЛЕФИНОВОЙ КОМПОЗИЦИИ АЦЕТАЛЬНЫМИ СОЕДИНЕНИЯМИ

Номер: RU2006141650A
Принадлежит:

... 1. Соединение где n равно 0, 1 или 2; Ar1 и Ar2 независимо выбраны из замещенных или незамещенных арилсодержащих групп и R выбран из группы, состоящей из алкенилов, алкилов, алкокси, гидроксиалкилов и алкилгалогенидов. 2. Соединение по п.1, где n = 0. 3. Соединение по п.1, где n = 1. 4. Соединение по п.1, где n = 2. 5. Соединение по п.1, где R представляет собой аллил. 6. Соединение по п.1, где R представляет собой пропил. 7. Полиолефинсодержащая композиция, включающая соединение по п.1. 8. Соединение по п.1, где R выбран из нижеследующих соединений: -СН3; -СН2СН3; -СН2СН2СН3; -СН2СН2СН2СН3; -СН2СН=СН2; -СН(СН3)СН=СН2; -СН2 СН-Х-СН2-Х'; -СН2СН2-Х"-СН2-СН3; -СН2СН-Х"'-СН2ОН; -СН-ОН-СН-ОН-СН2-ОН, где Х, Х', Х" и Х"', если они присутствуют, представляют собой независимо выбранные галогенидные группы. 9. Соединение по п.8, где Ar1 и Ar2 независимо выбраны из группы замещенных бензальдегидов, включая: бензальдегид, 4-этилбензальдегид, 4-изобутилбензальдегид, 4-фтор-3-метилбензальдегид, 5,6,7,8 ...

Подробнее
27-07-2011 дата публикации

ОРГАНИЧЕСКИЕ СОЕДИНЕНИЯ

Номер: RU2010101236A

1. Способ получения соединения формулы (I) ! ! где ! R1 означает OR3 или NR4R5; ! R2 означает C1-С7алкил или С3-С8циклоалкил; ! R3 означает водород, C1-С7алкил, фенил- или нафтилС1-С4алкил, арил, гетероциклил или С3-С8циклоалкил, каждый из которых незамещен или замещен; или означает SiRR'R'', где R, R' и R'' независимо друг от друга означают C1-С7алкил, арил или фенилС1-С4алкил; ! R4 и R5 независимо друг от друга означают водород, C1-C7алкил, фенил- или нафтилС1-С4алкил, арил, гетероциклил или С3-С8циклоалкил, каждый из которых незамещен или замещен; ! или R4 и R5 могут вместе образовывать 3-7-членное азотсодержащее насыщенное углеводородное кольцо, которое может содержать один или более гетероатомов, выбранных из N или О, и которое может быть незамещенным или замещенным; ! или его соль; ! где указанный процесс включает одну или более следующих стадий: ! с) введение соединения формулы (II) или его соли ! ! где R1 и R2 означают то, что определено для соединения формулы (I), в реакцию кросс-метатезиса с получением соединения формулы (III) или его соли ! ! где R1 и R2 означают то, что определено для соединения формулы (I); ! d) введение указанного соединения формулы (III) или его соли в реакцию гидрирования с получением соединения формулы (I) или его соли. ! 2. Способ получения соединения формулы (III) ! ! где ! R1 означает OR3 или NR4R5; ! R2 означает C1-С7алкил или С3-С8циклоалкил; ! R3 означает водород, C1-С7алкил, фенил- или нафтилС1-С4алкил, арил, гетероциклил или С3-С8циклоалкил, каждый из которых незамещен или замещен; или означает SiRR'R'', где R, R' и R'' независимо друг от друга означают C1-С7алкил, арил или фенилС1-С4алкил; ! R4 и R5 независимо друг от друга означают водород, C1-С7алкил, фенил- или нафтил� РОССИЙСКАЯ ФЕДЕРАЦИЯ (19) RU (11) 2010 101 236 (13) A (51) МПК C07C 51/00 (2006.01) ФЕДЕРАЛЬНАЯ СЛУЖБА ПО ИНТЕЛЛЕКТУАЛЬНОЙ СОБСТВЕННОСТИ, ПАТЕНТАМ И ТОВАРНЫМ ЗНАКАМ (12) ЗАЯВКА НА ИЗОБРЕТЕНИЕ (21)(22) Заявка: ...

Подробнее
23-06-1990 дата публикации

Способ получения С @ -С @ - алкиленкарбоната

Номер: SU1574175A3

Изобретение относится к гетероциклическим соединениям, в частности к получению C2-C4-алкиленкарбоната, которые применяются в качестве растворителей или в качестве источника соответствующих гликолей. Цель - увеличение конверсии алкиленоксида, упрощение процесса. Получение целевого соединения ведут реакцией C2-C4-алкиленоксида с двуокисью углерода в присутствии йодида или бромида метилтрифенилфосфония (катализатор) и воды при 30-170°С, давлении 25-104,8 кг/см2. Процесс ведут при молярном отношении двуокиси углерода к C2-C4-алкиленоксиду 1,3-56:1, воды к C2-C4-алкиленоксиду 0,06-4:1, катализатора к C2-C4-алкиленоксиду 0,14-0,0013:1 и парциальном давлении двуокиси углерода, равном 24,4-65 кг/см2. Способ обеспечивает увеличение конверсии оксида алкилена до 97,5%. 8 табл.

Подробнее
04-04-1979 дата публикации

Process for the production of heterocyclic compounds

Номер: GB0002004552A
Принадлежит:

A process is provided for the continuous or semi-continuous production of hetero-macrocyclic compounds including lactones and cyclic esters. The process involves the catalyzed depolymerization of a linear polyester at an elevated temperature and under reduced pressure in the presence of a specified amount of monocarboxylate moieties and while providing top-to-bottom mixing throughout essentially the total volume of the reaction mass.

Подробнее
15-10-1995 дата публикации

PROCEDURE FOR THE PRODUCTION OF VINYLETHERN.

Номер: AT0000128110T
Принадлежит:

Подробнее
15-09-2010 дата публикации

LIQUID CRYSTAL DISPLAY

Номер: AT0000479735T
Принадлежит:

Подробнее
15-10-1993 дата публикации

PROCEDURE AND COMPOSITIONS FOR the PRODUCTION of STRENGTHENING CHEMILUMINESZENZ OF 1,2-DIOXETANEN.

Номер: AT0000094895T
Принадлежит:

Подробнее
15-08-2006 дата публикации

1,2-DIOXETANE WITH IMPROVED CHEMOCLUMINESCENCE

Номер: AT0000334996T
Принадлежит:

Подробнее
15-10-2001 дата публикации

1,2-DIOXETANE WITH MORE IMPROVE CHEMILUMINESZENZ

Номер: AT0000205839T
Принадлежит:

Подробнее
15-04-2002 дата публикации

CHEMILUMINESZENZ ASSAY OF MEANS ENERGY TRANSFER

Номер: AT0000215696T
Принадлежит:

Подробнее
06-08-1998 дата публикации

Tri-substituted phenyl 1,2-dioxetanes

Номер: AU0000695229B2
Принадлежит:

Подробнее
21-06-2012 дата публикации

Leaving substituent-containing compound, organic semiconductor material, organic semiconductor film containing the material, organic electronic device containing the film, method for producing film-like product, pi-electron conjugated compound and method for producing the pi-electron conjugated compound

Номер: US20120153271A1
Принадлежит: Ricoh Co Ltd

A leaving substituent-containing compound including a partial structure represented by the following General Formula (I): where a pair of X 1 and X 2 or a pair of Y 1 and Y 2 each represent a hydrogen atom; the other pair each represent a group selected from the group consisting of a halogen atom and a substituted or unsubstituted acyloxy group having one or more carbon atoms; a pair of the acyloxy groups represented by the pair of X 1 and X 2 or the pair of Y 1 and Y 2 may be identical or different, or may be bonded together to form a ring; R 1 to R 4 each represent a hydrogen atom or a substituent; and Q 1 and Q 2 each represent a hydrogen atom, a halogen atom or a monovalent organic group, and may be bonded together to form a ring.

Подробнее
07-11-2013 дата публикации

MACROCYCLIC PICOLINAMIDES AS FUNGICIDES

Номер: US20130296373A1
Принадлежит: DOW AGROSCIENCES LLC

The disclosure relates to macrocyclic picolinamides of Formula I and their use as fungicides. 2. The compound according to claim 1 , wherein X and Y are independently chosen from H or C(O)R.3. The compound according to claim 2 , wherein Ris independently chosen from H claim 2 , alkyl claim 2 , alkenyl claim 2 , aryl claim 2 , heterocyclyl claim 2 , silyl claim 2 , —C(O)R claim 2 , each substituted with 0 claim 2 , 1 or multiple R.4. The compound according to claim 3 , wherein Ris independently phenyl or cyclohexyl.5. The compound according to claim 4 , wherein Ris alkyl or aryl substituted with 0 claim 4 , 1 claim 4 , or multiple R.6. The compound according to claim 5 , wherein Ris alkoxy or benzyloxy substituted with 0 claim 5 , 1 claim 5 , or multiple R.7. The compound according to claim 6 , wherein Ris hydrogen or alkyl.8. The compound according to claim 1 , wherein X is H and Y is Q.10. The compound according to claim 9 , wherein Ris independently chosen from alkyl claim 9 , aryl claim 9 , or —C(O)R claim 9 , each substituted with 0 claim 9 , 1 or multiple R.11. The compound according to claim 10 , wherein Ris phenyl.12. The compound according to claim 11 , wherein Ris alkyl substituted with 0 claim 11 , 1 claim 11 , or multiple R.13. The compound according to claim 12 , wherein Ris alkyl claim 12 , aryl claim 12 , alkoxy claim 12 , or halo.14. A composition for the control of a fungal pathogen including at least one of the compounds according to and a phytologically acceptable carrier material.16Mycosphaerella graminicolaSeptoria triticiPuccinia triticinaPuccinia striiformisVenturia inaequalisUstilago maydisUncinula necatorRhynchosporium secalisMagnaporthe griseaPseudoperonospora cubensisPhakopsora pachyrhiziLeptosphaeria nodorumBlumeria graministriticiBlumeria graminishordeiErysiphe cichoracearumGlomerella lagenariumCercospora beticolaAlternaria solaniPyrenophora teres. The composition according to claim claim 1 , 14 wherein the plant pathogen is at least one ...

Подробнее
07-11-2013 дата публикации

MACROCYCLIC PICOLINAMIDES AS FUNGICIDES

Номер: US20130296375A1
Принадлежит: DOW AGROSCIENCES LLC

The invention relates to macrocyclic picolinamides of Formula I and their use as fungicides. 2. A compound according to claim 1 , wherein:{'sub': '6', 'wherein, R is H, C(O)R;'}{'sub': 1', '6, 'Ris H, C(O)R;'}{'sub': 2', '5, 'Ris independently or separately H, alkyl, alkenyl, aryl, each substituted with 0, 1 or multiple R;'}{'sub': '3', 'Ris independently or separately H, methyl;'}{'sub': '5', 'Ris alkyl, alkoxy, halo, haloalkyl, or aryl; and'}{'sub': '6', 'Ris alkoxy, benzyloxy.'}5Mycosphaerella graminicolaSeptoria triticiPuccinia triticinaPuccinia striiformisVenturia inaequalisUstilago maydisUncinula necatorRhynchosporium secalisMagnaporthe griseaPseudoperonospora cubensisPhakopsora pachyrhiziLeptosphaeria nodorumBlumeria graministriticiBlumeria graminishordeiErysiphe cichoracearumGlomerella lagenariumCercospora beticolaAlternaria solaniPyrenophora teres. The compositions according to claim 4 , wherein the plant pathogen is least one pathogen selected from the group consisting of: Leaf Blotch of Wheat (; anamorph: ) claim 4 , Wheat Brown Rust () claim 4 , Stripe Rust () claim 4 , Scab of Apple () claim 4 , Blister Smut of Maize () claim 4 , Powdery Mildew of Grapevine () claim 4 , Barley scald () claim 4 , Blast of Rice () claim 4 , Downy Mildew of Cucurbits () claim 4 , Rust of Soybean () claim 4 , Glume Blotch of Wheat () claim 4 , Powdery Mildew of Wheat (f. sp. ) claim 4 , Powdery Mildew of Barley (f. sp. ) claim 4 , Powdery Mildew of Cucurbits () claim 4 , Anthracnose of Cucurbits () claim 4 , Leaf Spot of Beet () claim 4 , Early Blight of Tomato () claim 4 , and Net Blotch of Barley ().6Septoria triticiPuccinia triticinaPhakopsora pachyrhizi. The composition according to claim 5 , wherein the fungal pathogen is at least one of Leaf Blotch of Wheat () claim 5 , Wheat Brown Rust () claim 5 , and Rust of Soybean ().8. The method according to claim 7 , wherein the compound is applied in a mixture with at least one additional compound selected from the group ...

Подробнее
20-02-2014 дата публикации

INHIBITORS OF THE ACTIVITY OF COMPLEX III OF THE MITOCHONDRIAL ELECTRON TRANSPORT CHAIN AND USE THEREOF FOR TREATING DISEASES

Номер: US20140051678A1
Принадлежит: STEMERGIE BIOTECHNOLOGY SA

The present invention relates to compounds which are inhibitors of the activity of Complex III of the mitochondrial electron transport chain and pharmaceutical compositions comprising said compounds alone or in combination with other active agents. The present invention further relates to use of the compounds of the invention as medicaments or as agrochemicals where their properties as inhibitors of the mitochondrial respiration is of benefit. More particularly the present invention relates to the use of the compounds of the invention in a method of treating and/or preventing cancers presenting tumor-initiating cells. (Formula I) (I) 135.-. (canceled)37. The compound of claim 36 , wherein Ar is selected from (C5-C6)aromatic ring or (C5-C6)heteroaromatic ring where one or more of the carbon atoms in the ring system are replaced by heteroatoms selected from the group consisting of O claim 36 , S claim 36 , and N.38. The compound of claim 37 , wherein Ar is (C5-C6)aromatic ring.39. The compound of claim 36 , wherein A1 is —(C═O)—.40. The compound of claim 36 , wherein Aand Aare —C(═O)—.41. The compound of claim 36 , wherein Band Bare independently of each other selected from —O— claim 36 , —S— claim 36 , —NH— claim 36 , —CH— claim 36 , with the proviso that at least one of Band Bis not —O—.42. The compound of claim 36 , wherein Rand Rform together a (C3-C10)cycloalkyl or (C3-C10)heterocycloalkyl substituted by Rand R claim 36 , where Rand Rare independently of each other selected from —H claim 36 , —(C1-C10)alkyl claim 36 , —(C1-C10)alkenyl claim 36 , —(C1-C10)alkynyl claim 36 , mono or polyfluorinated (C1-C10)alkyl claim 36 , -aryl claim 36 , —OH claim 36 , —O—(C1-C10)alkyl claim 36 , —O—aryl claim 36 , —O(C═O)—(C1-C10)alkyl claim 36 , —O(C═O)-aryl claim 36 , and halogen.43. The compound of claim 36 , wherein R claim 36 , Rand Rare —H.44. The compound of claim 36 , wherein Rand Rform a bond together.45. The compound of claim 44 , wherein Aand Aare —C(═O)— and Ris H.46 ...

Подробнее
27-02-2014 дата публикации

2,2'-Binaphthalene Ester Chiral Dopants for Cholesteric Liquid Crystal Displays

Номер: US20140054498A1
Принадлежит: Kent Displays Inc, KENT STATE UNIVERSITY

A liquid crystal composition comprising a chiral dopant compound represented by the following structure (Structure 1): wherein: R1 and R2 are independently hydrogen, —(C═O)R9, —(C═O)R10, alkyl, aryl, alkaryl, alkenyl, cycloalkyl, alkoxyaryl, or heterocyclic all either substituted or unsubstituted, or combine to form a carbocyclic or heterocyclic ring; and R3-R9 are as described in the disclosure. Also featured are liquid crystal compositions comprising a chiral dopant compound represented by any of Structure 2-4 as described in the disclosure.

Подробнее
04-01-2018 дата публикации

MACROCYCLIC PICOLINAMIDE COMPOUNDS WITH FUNGICIDAL ACTIVITY

Номер: US20180002319A1
Принадлежит:

This disclosure relates to macrocyclic picolinamides of Formula I and their use as fungicides. 2. The compound according to claim 1 , wherein X and Y are hydrogen.3. The compound according to claim 2 , wherein Ris selected from the group consisting of hydrogen claim 2 , alkyl claim 2 , alkenyl claim 2 , and aryl claim 2 , each optionally substituted with 0 claim 2 , 1 claim 2 , or multiple R.4. (canceled)5. The compound according to claim 2 , wherein Ris independently selected for Rand Rfrom the group consisting of hydrogen claim 2 , alkyl claim 2 , alkenyl claim 2 , and aryl claim 2 , each optionally substituted with 0 claim 2 , 1 claim 2 , or multiple R.6. The compound according to claim 1 , wherein X is C(O)Rand Y is hydrogen.7. The compound according to claim 6 , wherein Ris selected from the group consisting of hydrogen claim 6 , alkyl claim 6 , alkenyl claim 6 , and aryl claim 6 , each optionally substituted with 0 claim 6 , 1 claim 6 , or multiple R.8. (canceled)9. The compound according to claim 6 , wherein Ris independently selected for Rand Rfrom the group consisting of hydrogen claim 6 , alkyl claim 6 , alkenyl claim 6 , and aryl claim 6 , each optionally substituted with 0 claim 6 , 1 claim 6 , or multiple R.10. The compound according to claim 1 , wherein X is hydrogen and Y is Q.11. The compound according to claim 10 , wherein Ris alkoxy.12. The compound according to claim 11 , wherein Ris hydrogen.13. The compound according to claim 12 , wherein Ris selected from the group consisting of hydrogen claim 12 , alkyl claim 12 , alkenyl claim 12 , and aryl claim 12 , each optionally substituted with 0 claim 12 , 1 claim 12 , or multiple R.14. (canceled)15. The compound according to claim 12 , wherein Ris independently selected for Rand Rfrom the group consisting of hydrogen claim 12 , alkyl claim 12 , alkenyl claim 12 , and aryl claim 12 , each optionally substituted with 0 claim 12 , 1 claim 12 , or multiple R.16. The compound according to claim 11 , ...

Подробнее
04-01-2018 дата публикации

USE OF MACROCYCLIC PICOLINAMIDES AS FUNGICIDES

Номер: US20180002320A1
Принадлежит:

This disclosure relates to macrocyclic picolinamides of Formula I and their use as fungicides. 2. A composition according to claim 1 , wherein X is hydrogen and Y is Q.3. A composition according to claim 2 , wherein Ris alkoxy.4. A composition according to claim 3 , wherein Ris hydrogen.5. A composition according to claim 4 , wherein Ris selected from the group consisting of hydrogen claim 4 , alkyl claim 4 , alkenyl claim 4 , and aryl claim 4 , each optionally substituted with 0 claim 4 , 1 claim 4 , or multiple R.6. (canceled)7. A composition according to claim 4 , wherein Ris independently selected for Rand Rfrom the group consisting of hydrogen claim 4 , alkyl claim 4 , alkenyl claim 4 , and aryl claim 4 , each optionally substituted with 0 claim 4 , 1 claim 4 , or multiple R.8. A composition according to claim 3 , wherein Ris selected from the group consisting of —C(O)Rand —CHOC(O)R.9. A composition according to claim 8 , wherein Ris alkyl claim 8 , optionally substituted with 0 claim 8 , 1 claim 8 , or multiple R.10. A composition according to claim 9 , wherein Ris selected from the group consisting of hydrogen claim 9 , alkyl claim 9 , alkenyl claim 9 , and aryl claim 9 , each optionally substituted with 0 claim 9 , 1 claim 9 , or multiple R.11. (canceled)12. A composition according to claim 9 , wherein Ris independently selected for Rand Rfrom the group consisting of hydrogen claim 9 , alkyl claim 9 , alkenyl claim 9 , and aryl claim 9 , each optionally substituted with 0 claim 9 , 1 claim 9 , or multiple R.13. A composition according to claim 12 , wherein Ris selected from the group consisting of —CH claim 12 , —CH(CH) claim 12 , and —CHOCHCH.14. A composition for the control of a fungal pathogen including at least one of the compositions of and a phytologically acceptable carrier material.15. A composition for the control of a fungal pathogen including at least one of the compositions of and a phytologically acceptable carrier material.16. (canceled)17. A ...

Подробнее
14-01-2016 дата публикации

MACROCYCLIC PICOLINAMIDES AS FUNGICIDES

Номер: US20160007601A1
Принадлежит:

This disclosure relates to macrocyclic picolinamides of Formula I and their use as fungicides. 2. The compound according to claim 1 , wherein X and Y are hydrogen.3. The compound according to claim 1 , wherein X is C(O)Rand Y is hydrogen.4. The compound according to claim 1 , wherein X is hydrogen and Y is Q.5. The compound according to claim 4 , wherein Ris hydrogen.6. The compound according to claim 4 , wherein Ris —C(O)Ror —CHOC(O)R.7. The compound according to claim 6 , wherein Ris alkyl or alkoxy claim 6 , each optionally substituted with 0 claim 6 , 1 claim 6 , or multiple R.8. The compound according to claim 7 , wherein Ris chosen from —CH claim 7 , —CH(CH) claim 7 , —CHOCHCH claim 7 , or —CHCHOCH.9. A composition for the control of a fungal pathogen including at least one of the compounds of and at least one additional compound selected from the group consisting of: a phytologically acceptable carrier material claim 1 , a second fungicide claim 1 , an insecticide claim 1 , a nematocides claim 1 , a miticide claim 1 , an arthropodicide claim 1 , a bactericide.10. The composition for the control of a fungal pathogen according to claim 9 , wherein the at least one additional compound is at least one phytologically acceptable carrier material.11Mycosphaerella graminicolaSeptoria triticiPuccinia triticinaPuccinia striiformisVenturia inaequalisUstilago maydisUncinula necatorRhynchosporium secalisMagnaporthe griseaPhakopsora pachyrhiziLeptosphaeria nodorumBlumeria graministriticiBlumeria graminishordeiErysiphe cichoracearumGlomerella lagenariumCercospora beticolaAlternaria solaniPyrenophora teres. The compositions according to claim 9 , wherein the fungal pathogen is at least one pathogen selected from the group consisting of: Leaf Blotch of Wheat (; anamorph: ) claim 9 , Wheat Brown Rust () claim 9 , Stripe Rust () claim 9 , Scab of Apple () claim 9 , Blister Smut of Maize () claim 9 , Powdery Mildew of Grapevine () claim 9 , Barley Scald () claim 9 , Blast of ...

Подробнее
14-01-2016 дата публикации

MACROCYCLIC PICOLINAMIDES AS FUNGICIDES

Номер: US20160007602A1
Принадлежит:

This disclosure relates to macrocyclic picolinamides of Formula I and their use as fungicides. 2. The compound according to claim 1 , wherein X and Y are hydrogen.3. The compound according to claim 2 , wherein Ris alkyl or aryl claim 2 , each optionally substituted with 0 claim 2 , 1 or multiple R.4. The compound according to claim 2 , wherein Ris hydrogen or alkyl claim 2 , each optionally substituted with 0 claim 2 , 1 or multiple R.5. The compound according to claim 1 , wherein X is C(O)Rand Y is hydrogen.6. The compound according to claim 5 , wherein Ris alkyl or aryl claim 5 , each optionally substituted with 0 claim 5 , 1 or multiple R.7. The compound according to claim 5 , wherein Ris hydrogen or alkyl claim 5 , each optionally substituted with 0 claim 5 , 1 or multiple R.8. The compound according to claim 1 , wherein X is hydrogen and Y is Q.9. The compound according to claim 8 , wherein Ris alkyl or aryl claim 8 , each optionally substituted with 0 claim 8 , 1 or multiple R.10. The compound according to claim 8 , wherein Ris hydrogen or alkyl claim 8 , each optionally substituted with 0 claim 8 , 1 or multiple R.11. The compound according to claim 9 , wherein Ris hydrogen.12. The compound according to claim 9 , wherein Ris —C(O)Ror —CHOC(O)R.13. The compound according to claim 12 , wherein Ris alkyl or alkoxy claim 12 , each optionally substituted with 0 claim 12 , 1 claim 12 , or multiple R.14. The compound according to claim 13 , wherein Ris —CH claim 13 , —CH(CH) claim 13 , —CHOCHCH claim 13 , or —CHCHOCH.15. A composition for the control of a fungal pathogen including at least one of the compounds of Formula I and at least one additional compound selected from the group consisting of: a phytologically acceptable carrier material claim 13 , a second fungicide claim 13 , an insecticide claim 13 , a nematocide claim 13 , a miticide claim 13 , an arthropodicide claim 13 , and a bactericide.16. The composition according to claim 15 , wherein the least one ...

Подробнее
10-01-2019 дата публикации

BIMESOGENIC COMPOUNDS AND MESOGENIC MEDIA

Номер: US20190010400A1
Принадлежит: Merck Patent GmBH

The invention relates to bimesogenic compounds of formula I 2. Bimesogenic compounds according to claim 1 , characterized in that MGand MGare independently of each other selected of partial formula II{'br': None, 'sup': 11', '11', '12, 'sub': 'k', '-A-(Z-A)- \u2003\u2003II'}wherein{'sup': '11', 'sub': 2', '2', '2', '2', '2', '2', '2', '4', '2', '2, 'Zare, independently of each other in each occurrence, a single bond, —COO—, —OCO—, —O—CO—O—, —OCH—, —CHO—, —OCF—, —CF)—, —CHCH—, —(CH)—, —CFCF—, —CH═CH—, —CF═CF—, —CH═CH—COO—, —OCO—CH═CH— or —C≡C—, optionally substituted with one or more of F, S and/or Si,'}{'sup': 11', '12, 'sub': '2', 'Aand Aare each independently in each occurrence 1,4-phenylene, wherein in addition one or more CH groups may be replaced by N, trans-1,4-cyclo-hexylene in which, in addition, one or two non-adjacent CHgroups may be replaced by O and/or S, 1,4-cyclohexenylene, 1,4-bicyclo-(2,2,2)-octylene, piperidine-1,4-diyl, naphthalene-2,6-diyl, decahydro-naphthalene-2,6-diyl, 1,2,3,4-tetrahydro-naphthalene-2,6-diyl, cyclobutane-1,3-diyl, spiro[3.3]heptane-2,6-diyl or dispiro[3.1.3.1] decane-2,8-diyl, it being possible for all these groups to be unsubstituted, mono-, di-, tri- or tetrasubstituted with F, Cl, CN or alkyl, alkoxy, alkylcarbonyl or alkoxycarbonyl groups with 1 to 7 C atoms, wherein one or more H atoms may be substituted by F or Cl, and'}k is 0, 1, 2, 3 or 4.3. Bimesogenic compounds according to claim 1 , characterized in that MGand MGare independently of one another selected from the group of formulae II-1 to II-26{'br': None, '-Phe-Z-Phe- \u2003\u2003II-1'}{'br': None, '-Phe-Z-Cyc- \u2003\u2003II-2'}{'br': None, '-Cyc-Z-Cyc- \u2003\u2003II-3'}{'br': None, '-Phe-Z-PheL- \u2003\u2003II-4'}{'br': None, '-PheL-Z-Phe- \u2003\u2003II-5'}{'br': None, '-PheL-Z-Cyc- \u2003\u2003II-6'}{'br': None, '-PheL-Z-PheL- \u2003\u2003II-7'}{'br': None, '-Phe-Z-Phe-Z-Phe- \u2003\u2003II-8'}{'br': None, '-Phe-Z-Phe-Z-Cyc- \u2003\u2003II-9'}{'br': None, '-Phe- ...

Подробнее
17-02-2022 дата публикации

CHEMILUMINESCENT PROBES FOR DIAGNOSTICS AND IN VIVO IMAGING

Номер: US20220047725A1
Принадлежит:

The present invention provides dioxetane-based chemiluminescence probes, more specifically fluorophore-tethered dioxetane-based chemiluminescence probes and compositions thereof. The chemiluminescence probes disclosed are useful for both diagnostics and in vivo imaging. 3. The conjugate of claim 2 , wherein Rand Rtogether with the carbon atom to which they are attached form adamantyl.4. The conjugate of claim 2 , wherein Xis —(CH)-para-phenylene; and Xis —C(O)—.5. The conjugate of claim 1 , wherein:{'sup': '1', 'sub': 1', '8, 'Ris a linear or branched (C-C)alkyl;'}{'sup': 2', '3, 'Rand Rtogether with the carbon atom to which they are attached form a fused, spiro or bridged polycyclic ring;'}{'sup': 7', '8', '9', '7', '8', '9, 'sub': '2', 'at least one of R, Rand Ris H, and the other of R, Rand Reach independently is an electron acceptor group selected from the group consisting of halogen, —NOand —CN; and'}{'sub': 1', '2', '1', '1', '18', '6', '14', '1', '18', '6', '14', '2', '2', '2', '2', '2', '3', '6', '10', '1', '4', '6', '10', '1', '4', '1', '18', '1', '8', '6', '10', '6', '10', '2, 'X is a linker of the formula —X—X—, wherein Xis (C-C)alkylene, (C-C)arylene-diyl, or (C-C)alkylene-(C-C)arylene-diyl, optionally substituted by one or more groups each independently selected from the group consisting of halogen, —COH, —COOH, —OCOOH, —OCONH, —CN, —NO, —SH, —OH, —NH, —CONH, —SOH, —SOH, —S(═O)H, (C-C)aryl, (C-C)alkylene-(C-C)aryl, heteroaryl, and (C-C)alkylene-heteroaryl, and said (C-C)alkylene being further optionally interrupted by one or more identical or different heteroatoms selected from the group consisting of S, O and N, and/or at least one group each independently selected from the group consisting of —NH—CO—, —CO—NH—, —N(C-Calkyl)-, —N(C-Caryl)-, (C-C)arylene-diyl, and heteroarylenediyl; and Xis —C(O)—.'}6. The conjugate of claim 5 , wherein Ris methyl; Rand Rtogether with the carbon atom to which they are attached form adamantly; Xis —(CH)-para-phenylene; ...

Подробнее
01-05-2014 дата публикации

2,2'-Binaphthalene Ester Chiral Dopants for Cholesteric Liquid Crystal Displays

Номер: US20140117284A1
Принадлежит: Kent Displays Inc, KENT STATE UNIVERSITY

A liquid crystal composition comprising a chiral dopant compound represented by the following structure (Structure 1): wherein: R1 and R2 are independently hydrogen, —(C═O)R9, —(C═O)R10, alkyl, aryl, alkaryl, alkenyl, cycloalkyl, alkoxyaryl, or heterocyclic all either substituted or unsubstituted, or combine to form a carbocyclic or heterocyclic ring; R3 is hydrogen, halogen, cyano, alkoxy, NHCOR9, NHSO2R9, COOR9, OCOR9, aryl, alkyl, alkenyl, cycloalkyl, or heterocyclic all either substituted or unsubstituted; R4 is hydrogen, alkyl, aryl, alkenyl, cycloalkyl, or heterocyclic all either substituted or unsubstituted; R5, R6, R7, and R8 are independently hydrogen, halogen, cyano, alkoxy, NHCOR9, NHSO2R9, COOR9, OCOR9, aryl, alkyl, alkenyl, cycloalkyl, alkoxyaryl or heterocyclic all either substituted or unsubstituted, or combine with each other, or R5 can combine with R4 to form a carbocyclic or heterocyclic ring; R9 and R10 are independently alkyl, alkoxy, aryl, naphthyl, styryl, alkenyl, cycloalkyl, alkoxyaryl, cycloalkoxy, or heterocyclic all either substituted or unsubstituted, or combine to form a carbocyclic or heterocyclic ring. Also featured are liquid crystal compositions comprising a chiral dopant compound represented by any of Structure 2-4.

Подробнее
25-02-2016 дата публикации

LIGHT UP-CONVERSION LUMINESCENT SUBSTANCE

Номер: US20160053168A1

[Problem] To provide a novel light up-conversion organic luminescent substance having a high light up-conversion efficiency. 5. The light up-conversion luminescent substance according to claim 1 , wherein group Xand group Xof the general formula (1) each independently represent a straight-chain alkylene group with a carbon number of 5 to 10 claim 1 , optionally having at least one bond selected from the group consisting of an ether bond claim 1 , an ester bond claim 1 , an amide bond claim 1 , and a sulfide bond.6. A light up-conversion material comprising the light up-conversion luminescent substance according to claim 1 , and a photosensitizer.7. The light up-conversion material according to claim 6 , further comprising a solvent claim 6 , a resin claim 6 , or a glass.8. A method of converting a light wavelength claim 6 , comprising irradiating the light up-conversion material according to with light to cause emission of light having a shorter wavelength than the radiating light. The present invention relates to a light up-conversion luminescent substance that converts long-wavelength light to short-wavelength light, and a light up-conversion material containing the same.In the related art, light up-conversion luminescent substances that convert long-wavelength light to short-wavelength light are known. The light up-conversion luminescent substances and inorganic light up-conversion luminescent substances in which a rare-earth element or the like is used are known. The inorganic light up-conversion luminescent substances have been applied, for example, to IR cards that convert infrared laser light to visible light, and have already been brought into practical use.On the other hand, when inorganic light up-conversion luminescent substances in which an organic compound is used, it is known that an intense and broad absorption spectrum of the organic compound is used to enable light up-conversion with broader wavelengths and lower incident power compared with the ...

Подробнее
20-02-2020 дата публикации

Flash and Glow 1,2-Dioxetanes

Номер: US20200056222A1
Принадлежит:

Compounds having chemiluminescent flash and glow properties. Also disclosed are methods using the compounds to generate light, detect and/or quantify enzymes, antigens, and/or nucleic acids. Also disclosed are kits relating to these compounds. 216.-. (canceled)17. The compound of claim 1 , wherein the cleavage of the bond cleavable by an enzyme moiety results in the generation of light at 25° C. which reaches a maximum in less than about 15 minutes.18. The compound of claim 17 , wherein the generation of light reaches a maximum in less than about 10 minutes.19. The compound of claim 17 , wherein the generation of light reaches a maximum in less than about 5 minutes.20. The compound of claim 1 , wherein the cleavage of the bond cleavable by an enzyme moiety results in the generation of light at 37° C. which reaches a maximum in less than about 15 minutes.21. The compound of claim 20 , wherein the generation of light reaches a maximum in less than about 10 minutes.22. The compound of claim 20 , wherein the generation of light reaches a maximum in less than about 5 minutes.24. A method for generating light claim 20 , comprising the steps of:{'claim-ref': {'@idref': 'CLM-00001', 'claim 1'}, '(a) providing the compound of ;'}(b) providing an enzyme complex comprising an enzyme moiety which is capable of cleaving the compound;(c) contacting the enzyme complex with the compound to form a reaction mixture; and,(d) allowing the reaction mixture to generate light.2584.-. (canceled)86. An assay method for determining the presence and/or amount of an enzyme in a sample claim 20 , comprising the steps of:{'claim-ref': {'@idref': 'CLM-00001', 'claim 1'}, '(a) providing the compound of ;'}(b) providing a sample suspected of comprising the enzyme which is capable of cleaving the compound so that it decomposes and generates light;(c) contacting the sample with the compound to form a reaction mixture; and,(d) detecting the light generated by the reaction mixture after addition of the ...

Подробнее
27-02-2020 дата публикации

TREPROSTINIL DERIVATIVE COMPOUNDS AND METHODS OF USING SAME

Номер: US20200062726A1
Принадлежит: CORSAIR PHARMA, INC.

Compounds represented by formulae I, II, III, and IV including pro-drugs for treprostinil and prostacyclin analogs. Uses include treatment of pulmonary hypertension (PH) or pulmonary arterial hypertension (PAH). The structures of the compounds can be adapted to the particular application for a suitable treatment dosage. Transdermal applications can be used. 181-. (canceled)83. The compound of claim 82 , wherein Ris Pand Ris H.84. The compound of claim 82 , wherein Ris H and Ris P.85. The compound of claim 82 , wherein Ris Pand Ris P.88. The compound of claim 82 , wherein each of Rto Ris H.89. The compound of claim 82 , wherein at least one of Rto Ris deuterium.90. The compound of claim 82 , wherein Z is —OH claim 82 , —OR claim 82 , —N(R)Ror P.91. The compound of claim 82 , wherein Z is P.92. The compound of claim 82 , wherein Z is —OH.93. A pharmaceutical composition comprising a compound of or a pharmaceutically acceptable salt thereof and one or more pharmaceutically acceptable carriers or excipients.94. The pharmaceutical composition of claim 93 , which is formulated for transdermal delivery claim 93 , optionally via a patch.95. A method of treating pulmonary hypertension claim 82 , comprising administering to a subject in need of treatment a therapeutically effective amount of a compound of or a pharmaceutically acceptable salt thereof.96. The method of claim 95 , wherein the pulmonary hypertension is pulmonary arterial hypertension.97. The method of claim 95 , wherein the compound is administered orally claim 95 , topically or parenterally.98. The method of claim 97 , wherein the compound is administered transdermally claim 97 , optionally via a patch.99. The method of claim 95 , further comprising administering an additional therapeutic agent.100. The method of claim 99 , wherein the additional therapeutic agent is selected from the group consisting of vasoactive agents claim 99 , diuretics claim 99 , anticoagulants and cardiac glycosides. This application is ...

Подробнее
23-03-2017 дата публикации

TREPROSTINIL DERIVATIVE COMPOUNDS AND METHODS OF USING SAME

Номер: US20170081303A1
Принадлежит:

Compounds represented by formulae I, II, III, and IV including pro-drugs for treprostinil and prostacyclin analogs. Uses include treatment of pulmonary hypertension (PH) or pulmonary arterial hypertension (PAH). The structures of the compounds can be adapted to the particular application for a suitable treatment dosage. Transdermal applications can be used. 181-. (canceled)83. The compound of claim 82 , wherein Ris H and Ris P.84. The compound of claim 82 , wherein Ris Pand Ris H.85. The compound of claim 82 , wherein Ris Pand Ris P.86. The compound of claim 82 , wherein Rand Rare each H.87. The compound of claim 82 , wherein each of Rto Ris H.88. The compound of claim 82 , wherein at least one of Rto Ris deuterium.89. A composition comprising at least one compound according to and at least one other component.90. The composition of claim 89 , which is formulated for transdermal delivery.91. The composition of claim 90 , which is formulated for transdermal delivery with a patch.92. The composition of claim 89 , further comprising at least one solvent.93. A method of treating pulmonary hypertension claim 82 , comprising administering to a subject in need of treatment a therapeutically effective amount of a compound of or a pharmaceutically acceptable salt claim 82 , solvate claim 82 , polymorph or enantiomer thereof.94. The method of claim 93 , wherein the pulmonary hypertension is pulmonary arterial hypertension.95. The method of claim 93 , wherein the compound is administered topically.96. The method of claim 95 , wherein the compound is administered transdermally.97. The method of claim 96 , wherein the compound is administered via a transdermal patch.98. The method of claim 93 , further comprising administering an additional therapeutic agent.99. The method of claim 98 , wherein the additional therapeutic agent is selected from the group consisting of vasoactive agents claim 98 , diuretics claim 98 , anticoagulants and cardiac glycosides. This application is a ...

Подробнее
29-03-2018 дата публикации

TREPROSTINIL DERIVATIVE COMPOUNDS AND METHODS OF USING SAME

Номер: US20180086730A1
Принадлежит:

Compounds represented by formulae I, II, III, and IV including pro-drugs for treprostinil and prostacyclin analogs. Uses include treatment of pulmonary hypertension (PH) or pulmonary arterial hypertension (PAH). The structures of the compounds can be adapted to the particular application for a suitable treatment dosage. Transdermal applications can be used. 147-. (canceled)49. The compound of claim 48 , wherein R claim 48 , R claim 48 , R claim 48 , R claim 48 , R claim 48 , R claim 48 , R claim 48 , R claim 48 , R claim 48 , R claim 48 , R claim 48 , R claim 48 , R claim 48 , R claim 48 , R claim 48 , R claim 48 , and Rare H.50. The compound of claim 48 , wherein at least one of R claim 48 , R claim 48 , R claim 48 , R claim 48 , R claim 48 , R claim 48 , R claim 48 , R claim 48 , R claim 48 , R claim 48 , R claim 48 , R claim 48 , R claim 48 , R claim 48 , R claim 48 , R claim 48 , and Rare is deuterium.51. The compound of claim 48 , wherein Lis —O-alkylene-C(O)—.52. The compound of claim 48 , wherein Lis —O-alkylene-OC(O)—.53. The compound of claim 48 , wherein Lis a bond.54. The compound of claim 48 , wherein the alkylene group is a C-Calkylene group.55. The compound of claim 48 , wherein the alkylene group is a Calkylene group.56. (canceled)5863-. (canceled)66. A composition comprising a compound of claim 48 , or and one or more pharmaceutically acceptable excipients.67. The composition of claim 66 , which is formulated for transdermal delivery.6870-. (canceled)71. A method of treating pulmonary hypertension claim 66 , comprising administering to a subject in need of treatment a therapeutically effective amount of a compound of claim 66 , or or a pharmaceutically acceptable salt thereof.72. The method of claim 71 , wherein the pulmonary hypertension is pulmonary arterial hypertension.73. The method of claim 71 , wherein the compound is administered transdermally. This application claims priority to U.S. provisional application 61/751,608 filed Jan. 11, 2013 ...

Подробнее
30-03-2017 дата публикации

MACROCYCLIC COMPOUNDS, POLYMERS, AND METHODS FOR MAKING SAME

Номер: US20170088536A1
Принадлежит:

The application relates to macrocyclic compounds and related polymers, as well as to processes for synthesizing them, e.g., using olefins as starting material. 24.-. (canceled)5. The compound of claim 1 , wherein claim 1 , for the compound of Formula I claim 1 , the number of atoms comprising the ring structure is between 13 and 19.6. The compound of claim 1 , wherein X is O.7. The compound of claim 1 , wherein X is NH.8. The compound of claim 1 , wherein Z is hydrogen.10. The compound of claim 1 , wherein Ris optionally substituted linear CCalkyl branched C-Calkyl claim 1 , unsubstituted linear C-Calkyl claim 1 , optionally substituted linear C-Calkenyl claim 1 , unsubstituted linear C-Calkenyl or branched C-Calkenyl.1113.-. (canceled)14. The compound of claim 1 , wherein Ris optionally substituted linear CCalkyl claim 1 , unsubstituted linear CCalkyl or branched C-Calkyl.15. The compound of claim 1 , wherein Ris linear CCalkyl or branched C-Calkyl substituted with one or more hydroxyl groups.16. (canceled)17. The compound of claim 1 , wherein Ris optionally substituted linear C-Calkenyl claim 1 , unsubstituted linear C-Calkenyl or branched C-Calkenyl.18. (canceled)19. The compound of claim 1 , wherein Ris optionally substituted linear C-Calkynyl claim 1 , unsubstituted linear C-Calkynyl or branched C-Calkynyl.20. (canceled)24. (canceled)25. The method of claim 23 , further comprising an amidation step claim 23 , wherein a compound of Formula I claim 23 , wherein X is O claim 23 , reacts with NHunder an elevated pressure to obtain a corresponding compound of Formula I claim 23 , wherein X is NH.26. (canceled)27. The method of claim 23 , wherein the esterification step is performed at a first temperature that is greater than room temperature claim 23 , and the etherification step is performed at a second temperature that is lower than the first temperature.2833.-. (canceled)34. The method of claim 23 , wherein the etherification step is quenched with a base.35. ( ...

Подробнее
02-04-2015 дата публикации

MACROCYCLIC PICOLINAMIDE COMPOUNDS WITH FUNGICIDAL ACTIVITY

Номер: US20150094339A1
Принадлежит:

The invention relates to compounds of macrocyclic picolinamides of Formula I suitable to control or prevent growth of fungi. 2. The compound according to claim 1 , wherein X and Y are independently chosen from H or C(O)R.3. The compound according to claim 2 , wherein Ris chosen from H claim 2 , alkyl claim 2 , alkenyl claim 2 , aryl claim 2 , —Si(R) claim 2 , or —C(O)R claim 2 , each optionally substituted with 0 claim 2 , 1 or multiple R.4. The compound according to claim 3 , wherein Ris chosen from H claim 3 , alkyl claim 3 , aryl claim 3 , heteroaryl claim 3 , or arylalkyl claim 3 , each optionally substituted with 0 claim 3 , 1 or multiple R.5. The compound according to claim 1 , wherein X is H and Y is Q.6. The compound according to claim 5 , wherein Ris chosen from H claim 5 , alkyl claim 5 , alkenyl claim 5 , aryl claim 5 , —Si(R) claim 5 , or —C(O)R claim 5 , each optionally substituted with 0 claim 5 , 1 or multiple R.7. The compound according to claim 6 , wherein Ris chosen from H claim 6 , alkyl claim 6 , aryl claim 6 , heteroaryl claim 6 , or arylalkyl claim 6 , each optionally substituted with 0 claim 6 , 1 or multiple R.8. The compound according to claim 7 , wherein Ris H claim 7 , —C(O)R claim 7 , or —CHOC(O)R.9. The compound according to claim 8 , wherein Ris alkyl or alkoxy claim 8 , each optionally substituted with 0 claim 8 , 1 claim 8 , or multiple R.10. A formulation for the control of a fungal pathogen claim 8 , comprising:{'claim-ref': {'@idref': 'CLM-00001', 'claim 1'}, 'at least one of the compounds of ; and'}a phytologically acceptable carrier material.11. The formulation according to claim 10 , wherein the formulation is suitable for treating plants.12. A formulation for the control of a fungal pathogen claim 10 , comprising:{'claim-ref': {'@idref': 'CLM-00001', 'claim 1'}, 'at least one of the compounds of ; and'}at least one agriculturally active ingredient selected from the group consisting of: fungicides, insecticides, nematocides, ...

Подробнее
02-04-2015 дата публикации

Use of macrocyclic picolinamides as fungicides

Номер: US20150094340A1
Принадлежит: DOW AGROSCIENCES LLC

The invention relates to macrocyclic picolinamides of Formula I and their use as fungicides.

Подробнее
12-05-2022 дата публикации

CHRYSOPHAENTIN ANALOGS AND USE THEREOF

Номер: US20220144794A1
Принадлежит:

Provided are 9-dechlorochrysophaentin analog compounds and the synthesis process thereof. The disclosed compound have remarkable antimicrobial activities that are comparable to, or even more potent than, the natural product chrysophaentin A. Also provided are method of inhibiting bacterial growth or treating bacterial infection by administering an effective amount of the disclosed compounds. 3. The compound of any one of - , or a pharmaceutically acceptable salt thereof , wherein Y is halogen and Z is H.4. The compound of any one of - , or a pharmaceutically acceptable salt thereof , wherein Y is H and Z is halogen.5. The compound of any one of - , or a pharmaceutically acceptable salt thereof , wherein R , R , R , R , R , and Rare independently H or Calkyl.6. The compound of any one of - , or a pharmaceutically acceptable salt thereof , wherein R , R , R , R , R , and Rare independently H , methyl , or isopropyl.7. The compound of any one of - , or a pharmaceutically acceptable salt thereof , wherein R , R , and Rare H; and R , R , and Rare independently H , methyl , or isopropyl.8. The compound of any one of - , or a pharmaceutically acceptable salt thereof , wherein R , R , Rand Rare H; and Rand Rare independently H , methyl , or isopropyl.9. The compound of any one of - , or a pharmaceutically acceptable salt thereof , wherein{'sup': 1', '2', '3', '4', '5', '6, 'R, R, RR, R, and Rare H, Y is halogen, Z is H;'}{'sup': 1', '2', '3', '4', '5', '6, 'R, R, RR, R, and Rare H, Y is H, Z is halogen;'}{'sup': 1', '2', '3', '4', '5', '6, 'R, R, Rand Rare H; Rand Rare methyl, Y is halogen, Z is H; or'}{'sup': 1', '2', '3', '4', '5', '6, 'R, R, Rand Rare H; Rand Rare methyl, Y is H, Z is halogen.'}10. The compound of claim 9 , or a pharmaceutically acceptable salt thereof claim 9 , wherein{'sup': 1', '2', '3', '4', '5', '6, 'R, R, RR, R, and Rare H, Y is Cl, and Z is H.'}11. The compound of claim 9 , or a pharmaceutically acceptable salt thereof claim 9 , wherein{'sup': 1', ...

Подробнее
03-07-2014 дата публикации

SYNTHESIS AND USE OF ISOTOPICALLY LABELED MACROCYCLIC COMPOUNDS

Номер: US20140186873A1
Принадлежит:

Disclosed herein are isotopically labeled antifungal antibiotics and related compounds. Also disclosed are methods for synthesizing these isotopically labeled molecules and using the same to study the distribution of these compounds in the biosphere as well as the products formed by the breakdown of these isotopically labeled compounds. 4. The compound according to claim 1 , wherein Ris H.9. The compound according to claim 5 , wherein Ris Ph-C10. The compound according to claim 5 , wherein Ris Ph-UL-C.12. The method according to claim 11 , wherein the compound is (a) and the sample is a portion of a plant.13. The method according to claim 11 , wherein the compound is (a) and the sample is from a surface adjacent to a plant.14. The method according to claim 11 , wherein the compound is (a) and the sample is from a material that is in communication with a surface adjacent to a plant.15. The method according to claim 11 , where the compound is (a) and the isotopically labeled signature is contained in a portion of said compound.16. The method according to claim 11 , wherein the compound is (b) and the sample is a portion of a plant.17. The method according to claim 11 , wherein the compound is (b) and the sample is from a surface adjacent to a plant.18. The method according to claim 11 , wherein the compound is (b) and the sample is from a material that is in communication with a surface adjacent to a plant.19. The method according to claim 11 , where the compound is (b) and the isotopically labeled signature is contained in a portion of said compound. This application claims the benefit of U.S. Provisional Patent Application Ser. No. 61/747,699 filed Dec. 31, 2012, which is expressly incorporated by reference herein.Aspects of the invention include the preparation and use of isotopically labeled compounds including radiolabeled forms of the antifungal antibiotic UK-2A and related compounds.Isotopically labeled compounds are important tools in characterizing the role ...

Подробнее
03-07-2014 дата публикации

Dioxirane compounds and uses thereof

Номер: US20140187467A1
Автор: Kraig Anderson
Принадлежит: Individual

A dioxirane-containing compound has a first substituent that is an alkyl, polyalkoxy, aryl, heteroaryl, or heterocyclyl group, and a second substituent that is an electron withdrawing group, and where the first and second substituents can optionally join to form a cycloalkyl or heterocyclyl group. The dioxirane-containing compound can be used as an oxidant, surfactant, and/or an ionic liquid.

Подробнее
29-04-2021 дата публикации

Amphiphilic and Mesogenic Organic Dyes for Tailor-Made Reflective Low-Dimensional Materials

Номер: US20210122742A1
Принадлежит:

The present invention relates to a compound of the following formula (I): 2. The compound according to claim 1 , wherein R═R′.5. The compound according to any one of to claim 1 , wherein Rrepresents a halogen atom claim 1 , a (C-C)alkyl claim 1 , (C-C)haloalkyl claim 1 , (CH)OR claim 1 , (CH)SR claim 1 , OR claim 1 , SRor NRRgroup claim 1 , wherein m and m′ are claim 1 , independently of each other claim 1 , equal to 1 claim 1 , 2 or 3 claim 1 , preferably 1.6. The compound according to any one of to claim 1 , wherein:{'sub': 4', '1', '20', '1', '20', '2', 'm', '24', '2', 'm', '25', '26', '27', '28', '29, 'Rrepresents a halogen atom, a (C-C)alkyl, (C-C)haloalkyl, (CH)OR, (CH)SR, OR, SRor NRRgroup wherein m and m′ are, independently of each other, equal to 1, 2 or 3, preferably 1;'}or{'sub': 4', '42', '43', '2', 'n', '44', '45', '2', '2, 'claim-text': Y and Y′ each represent, independently of each other, O, S or NH,', 'n is equal to 2 or 3,', {'sub': 42', '43', '1', '6, 'Rand R, each represent, independently of each other, a (C-C)alkyl group, and'}, {'sub': 44', '45', '1', '6, 'Rand Reach represent, independently of each other, a (C-C)alkyl group.'}], 'both Rgroups form together a bond or a chain selected from the group consisting of —C(RR)—, —(CH)—, —Si(RR)— and —Y—CH—CH—Y′—, wherein7. The compound according to any one of to claim 1 , wherein L represents a bond.8. The compound according to any one of to claim 1 , wherein Rand Reach represent claim 1 , independently of each other claim 1 , a hydrogen atom claim 1 , a halogen atom claim 1 , a (C-C)alkyl or (C-C)haloalkyl group claim 1 , notably a hydrogen atom or a (C-C)alkyl group claim 1 , preferably Rand Rboth represent a hydrogen atom.9. The compound according to any one of to claim 1 , wherein R═Rand/or R═Rand/or R═R.11. The compound according to any one of to claim 1 , wherein A represents a hexafluorophosphate claim 1 , tetrafluoroborate claim 1 , tetraphenylborate claim 1 , 2 claim 1 ,3-dichloro-5 claim 1 ,6- ...

Подробнее
03-05-2018 дата публикации

BROMINE-SENSITIZED SOLAR PHOTOLYSIS OF CARBON DIOXIDE

Номер: US20180119275A1
Автор: BRAIMAN Mark S.
Принадлежит:

There is described a process for depositing carbon on a surface, comprising, while contacting a mixture of COand Brwith a polar substrate presenting apposed surfaces, exposing a sufficient area of said mixture in the region of said apposed surfaces to light of sufficient intensity and frequency to result in deposition of carbon on at least some of said apposed surfaces. Other embodiments are also described. 146-. (canceled)47. A composition of matter comprising a chemical compound of the formula COBr.48. The composition of matter of claim 47 , wherein said chemical compound of formula COBris a substituted 1 claim 47 ,3-dioxetane.49. The composition of matter of claim 48 , where the substituted 1 claim 48 ,3-dioxetane is 2 claim 48 ,4-dibromo-2 claim 48 ,4-dihypobromo-1 claim 48 ,3-dioxetane.50. The composition of matter of claim 49 , where the 2 claim 49 ,4-dibromo-2 claim 49 ,4-dihypobromo-1 claim 49 ,3-dioxetane has the two hypobromo groups in a trans configuration.51. The composition of matter of claim 49 , where the 2 claim 49 ,4-dibromo-2 claim 49 ,4-dihypobromo-1 claim 49 ,3-dioxetane has the two hypobromo groups in a cis configuration.52. The composition of matter according to claim 47 , wherein the composition of matter consists essentially of said compound.53. The composition of matter according to claim 48 , wherein the composition of matter consists essentially of said compound.54. The composition of matter according to claim 49 , wherein the composition of matter consists essentially of said compound.55. The composition of matter according to claim 50 , wherein the composition of matter consists essentially of said compound.56. The composition of matter according to claim 51 , wherein the composition of matter consists essentially of said compound.57. A chemical compound of the formula COBr.58. The chemical compound of claim 57 , wherein said chemical compound is a substituted 1 claim 57 ,3-dioxetane.59. The chemical compound of claim 58 , where the ...

Подробнее
25-04-2019 дата публикации

COMPOUNDS AND THE USE THEREOF IN METATHESIS REACTIONS

Номер: US20190119311A1
Принадлежит:

The disclosure provides Group 6 complexes, which, in some embodiments, are useful for catalyzing olefin metathesis reactions. In some embodiments, the compounds are compounds of the following formula: 2. The compound of claim 1 , wherein Ris phenyl claim 1 , 2 claim 1 ,6-dichlorophenyl claim 1 , 2 claim 1 ,6-dimethylphenyl claim 1 , 2 claim 1 ,6-diisopropylphenyl claim 1 , 2-trifluoromethylphenyl claim 1 , pentafluorophenyl claim 1 , tert-butyl claim 1 , or 1-adamantyl.3. The compound of claim 1 , wherein Ris pyrrol-1-yl claim 1 , 2 claim 1 ,5-dimethylpyrrol-1-yl claim 1 , 2 claim 1 ,5-diphenylpyrrol-1-yl claim 1 , or indol-1-yl.5. The compound of claim 1 , wherein Ris methyloxy claim 1 , ethyloxy claim 1 , or isopropyloxy.6. The compound of claim 1 , wherein Rand Rare independently a hydrogen atom claim 1 , methyl claim 1 , a halogen atom claim 1 , or methyloxy.7. A method for carrying out a metathesis reaction claim 1 , the method comprising:providing a first compound having one or more carbon-carbon double bonds; and{'claim-ref': {'@idref': 'CLM-00001', 'claim 1'}, 'reacting the first compound via a metathesis reaction in the presence of a compound of .'}8. The method of claim 7 , wherein the first compound has two or more carbon-carbon double bonds.9. The method of claim 8 , wherein the metathesis reaction is a ring-closing metathesis reaction between two of the two or more carbon-carbon double bonds of the first compound.10. A method of carrying out a metathesis reaction claim 8 , the method comprising:providing a first compound having one or more carbon-carbon double bond and a second compound having one or more carbon-carbon double bonds; and{'claim-ref': {'@idref': 'CLM-00001', 'claim 1'}, 'reacting the first compound and the second compound via a metathesis reaction in the presence of a compound of .'}11. The method of claim 10 , wherein the first compound and the second compound are the same compound.12. The method of claim 10 , wherein the first compound ...

Подробнее
16-04-2020 дата публикации

NEW ADIPATE-TYPE COMPOUNDS AND A PROCESS OF PREPARING IT

Номер: US20200115359A1
Принадлежит: Haldor Topsoe A/S

New adipate-type compounds suitable as an intermediate in organic chemistry, a platform chemical for the production of other chemicals, and as a monomer and a co-monomer useful for the preparation of polymers and co-polymers. Also, a process of preparing the new adipate-type compounds from bio-based raw materials such as sugars. 2. The compound according to claim 1 , wherein n is 2.3. The compound according to claim 1 , wherein n is 3.5. The process according to claim 4 , wherein n is 2.6. The process according to claim 4 , wherein n is 3.7. The process according to claim 4 , wherein the conversion temperature of iii) is in the range of from 20 to 120° C.8. The process according to claim 4 , wherein step iii) is continued for a period of time in the range of from 5 minutes to 24 hours.9. The process according to claim 4 , wherein the conversion step of iii) is conducted at a pressure in the range of from 1 to 1000 kPa claim 4 , such as from 10 to 125 kPa.10. The process according to claim 4 , wherein the conversion step of iii) is conducted in the presence of a solvent selected from methyl lactate claim 4 , ethyl lactate claim 4 , toluene claim 4 , dichlormethane claim 4 , or mixtures thereof. The present application is a divisional of U.S. application Ser. No. 16/096,103, filed on Oct. 24, 2018, which is a U.S. National Stage of International Application No. PCT/EP2017/060702, filed on May 4, 2017, which claims the benefit of Danish Application No. PA 2016-00273, filed on May 4, 2016. The entire contents of each of U.S. application Ser. No. 16/096,103, International Application No. PCT/EP2017/060702, Danish Application No. PA 2016-00273 are hereby incorporated herein by reference in their entirety.The present invention regards a new compound suitable as an intermediate in organic chemistry, a platform chemical for the production of other chemicals, and as a monomer and co-monomer useful for the preparation of polymers and co-polymers. The invention also regards the ...

Подробнее
16-05-2019 дата публикации

NEW ADIPATE-TYPE COMPOUNDS AND A PROCESS OF PREPARING IT

Номер: US20190144415A1
Принадлежит: Haldor Topsoe A/S

The present invention regards new adipate-type compounds suitable as an intermediate in organic chemistry, a platform chemical for the production of other chemicals, and as a monomer and co-monomer useful for the preparation of polymers and copolymers. The invention also regards the process of preparing the new adipate-type compounds from bio-based raw materials such as sugars.

Подробнее
18-06-2015 дата публикации

TREPROSTINIL DERIVATIVE COMPOUNDS AND METHODS OF USING SAME

Номер: US20150166503A1
Принадлежит:

Compounds represented by formulae I, II, III, and IV including pro-drugs for treprostinil and prostacyclin analogs. Uses include treatment of pulmonary hypertension (PH) or pulmonary arterial hypertension (PAH). The structures of the compounds can be adapted to the particular application for a suitable treatment dosage. Transdermal applications can be used. 2. The compound of claim 1 , wherein Ris Pand Ris H.3. The compound of claim 1 , wherein Ris H and Ris P.4. The compound of claim 1 , wherein Ris Pand Ris P.615-. (canceled)16. The compound of claim 1 , wherein R claim 1 , R claim 1 , R claim 1 , R claim 1 , R claim 1 , R claim 1 , R claim 1 , R claim 1 , R claim 1 , R claim 1 , R claim 1 , R claim 1 , R claim 1 , R claim 1 , R claim 1 , R claim 1 , and Rare H claim 1 , or wherein at least one of R claim 1 , R claim 1 , R claim 1 , R claim 1 , R claim 1 , R claim 1 , R claim 1 , R claim 1 , R claim 1 , R claim 1 , R claim 1 , R claim 1 , R claim 1 , R claim 1 , R claim 1 , R claim 1 , and Rare deuterium.17. (canceled)18. The compound of claim 1 , wherein Z is —OR claim 1 , —N(R)R claim 1 , or P.19. (canceled)20. The compound of claim 1 , wherein Z is —OH claim 1 , —OR claim 1 , —N(R)R claim 1 , or P.21. (canceled)22. The compound of claim 1 , wherein Z is not —OH and Ris not unsubstituted or substituted benzyl.25. The compound of claim 24 , wherein Z is —OR.26. The compound of claim 24 , wherein Z is —N(R)R.27. The compound of claim 24 , wherein Z is —SR.28. The compound of claim 24 , wherein Z is P.29. The compound of claim 24 , wherein Z is ORand Ris bicycloalkyl claim 24 , alkylcycloalkyl claim 24 , or alkylcycloheteroalkyl.30. The compound of claim 24 , wherein Ris haloalkyl.31. (canceled)32. The compound of claim 24 , wherein Ris hydrogen and Ris P.33. The compound of claim 24 , wherein Ris Pand Ris hydrogen.34. The compound of claim 24 , wherein Ris Pand Ris P.35. The compound of claim 24 , wherein Rand Rare each hydrogen.36. A compound according to claim ...

Подробнее
24-06-2021 дата публикации

Compound, mixture, liquid crystal composition, cured product, optically anisotropic body, and reflective film

Номер: US20210189243A1
Принадлежит: Fujifilm Corp

An object of the present invention is to provide a compound which increases the intensity of HTP by exposure to irradiation with light such as ultraviolet rays, and a mixture including the compound. Another object of the present invention is to provide a liquid crystal composition, a cured product, an optically anisotropic body, and a reflective film.The compound of the present invention is represented by General Formula (1).

Подробнее
14-06-2018 дата публикации

TREPROSTINIL DERIVATIVE COMPOUNDS AND METHODS OF USING SAME

Номер: US20180162829A1
Принадлежит:

Compounds represented by formulae I, II, III, and IV including pro-drugs for treprostinil and prostacyclin analogs. Uses include treatment of pulmonary hypertension (PH) or pulmonary arterial hypertension (PAH). The structures of the compounds can be adapted to the particular application for a suitable treatment dosage. Transdermal applications can be used. 157-. (canceled)60. The compound of claim 58 , wherein R claim 58 , R claim 58 , R claim 58 , R claim 58 , R claim 58 , R claim 58 , R claim 58 , R claim 58 , R claim 58 , R claim 58 , R claim 58 , R claim 58 , R claim 58 , R claim 58 , R claim 58 , R claim 58 , and Rare H.61. The compound of claim 58 , wherein at least one of R claim 58 , R claim 58 , R claim 58 , R claim 58 , R claim 58 , R claim 58 , R claim 58 , R claim 58 , R claim 58 , R claim 58 , R claim 58 , R claim 58 , R claim 58 , R claim 58 , R claim 58 , R claim 58 , and Ris deuterium.62. (canceled)64. (canceled)65. (canceled)66. A composition comprising a compound of or a pharmaceutically acceptable salt thereof and one or more pharmaceutically acceptable carriers or excipients.67. The composition of claim 66 , which is formulated for transdermal delivery.68. The composition of claim 66 , which is formulated for transdermal delivery with a patch.6972-. (canceled)73. A method of treating pulmonary hypertension claim 58 , comprising administering to a subject in need of treatment a therapeutically effective amount of a compound of or a pharmaceutically acceptable salt thereof.74. (canceled)75. (canceled)76. The method of claim 73 , wherein the compound is administered orally claim 73 , topically or parenterally.77. The method of claim 76 , wherein the compound is administered transdermally.78. The method of claim 73 , wherein the pulmonary hypertension is pulmonary arterial hypertension.79. The method of claim 73 , further comprising administering an additional therapeutic agent.80. The method of claim 79 , wherein the additional therapeutic agent is ...

Подробнее
25-06-2015 дата публикации

Bimesogenic Compounds and Mesogenic Media

Номер: US20150175883A1
Принадлежит: Merck Patent GmBH

The invention relates to bimesogenic compounds of formula I 4. Bimesogenic compounds according to claim 1 , characterized in that Ris selected from OCF claim 1 , CF claim 1 , F claim 1 , Cl and CN.5. Bimesogenic compounds according to claim 1 , characterized in that Spis —(CH)— and o is 1 claim 1 , 3 or an integer from 5 to 15.6. (canceled)7. Liquid-crystalline medium claim 1 , characterised in that it comprises one or more bimesogenic compounds according to .9. (canceled)10. Liquid crystal device comprising a liquid crystalline medium comprising two or more components claim 1 , one or more of which is a bimesogenic compound of formula I according to .11. Liquid crystal device according to claim 10 , characterized in that it is a flexoelectric device. The invention relates to bimesogenic compounds of formula Iwherein R, R, MG, MGand Sphave the meaning given herein below, to the use of bimesogenic compounds of formula I in liquid crystal media and particular to flexoelectric liquid crystal devices comprising a liquid crystal medium according to the present invention.Liquid Crystal Displays (LCDs) are widely used to display information. LCDs are used for direct view displays, as well as for projection type displays. The electro-optical mode which is employed for most displays still is the twisted nematic (TN)-mode with its various modifications. Besides this mode, the super twisted nematic (STN)-mode and more recently the optically compensated bend (OCB)-mode and the electrically controlled birefringence (ECB)-mode with their various modifications, as e. g. the vertically aligned nematic (VAN), the patterned ITO vertically aligned nematic (PVA)-, the polymer stabilized vertically aligned nematic (PSVA)-mode and the multi domain vertically aligned nematic (MVA)-mode, as well as others, have been increasingly used. All these modes use an electrical field, which is substantially perpendicular to the substrates, respectively to the liquid crystal layer. Besides these ...

Подробнее
02-07-2015 дата публикации

USE OF MACROCYCLIC PICOLINAMIDES AS FUNGICIDES

Номер: US20150181868A1
Принадлежит:

The invention relates to macrocyclic picolinamides of Formula I and their use as fungicides. 2. A composition according to claim 1 , wherein X is hydrogen and Y is Q.3. A composition according to claim 2 , wherein Ris hydrogen.4. A composition according to claim 3 , wherein Ris chosen from alkyl and aryl claim 3 , each optionally substituted with 0 claim 3 , 1 or multiple R.5. A composition according to claim 3 , wherein Ris chosen from hydrogen claim 3 , alkyl claim 3 , aryl claim 3 , and acyl claim 3 , each optionally substituted with 0 claim 3 , 1 or multiple R.6. A composition according to claim 3 , wherein Ris chosen from alkyl and aryl claim 3 , each optionally substituted with 0 claim 3 , 1 or multiple R claim 3 , and Ris chosen from hydrogen claim 3 , alkyl claim 3 , aryl claim 3 , and acyl claim 3 , each optionally substituted with 0 claim 3 , 1 or multiple R.7. A composition according to claim 2 , wherein Ris —C(O)Ror —CHOC(O)R.8. A composition according to claim 7 , wherein Ris chosen from alkyl and alkoxy claim 7 , each optionally substituted with 0 claim 7 , 1 claim 7 , or multiple R.9. A composition according to claim 8 , wherein Ris chosen from alkyl and aryl claim 8 , each optionally substituted with 0 claim 8 , 1 or multiple R.10. A composition according to claim 8 , wherein Ris chosen from hydrogen claim 8 , alkyl claim 8 , aryl claim 8 , and acyl claim 8 , each optionally substituted with 0 claim 8 , 1 or multiple R.11. A composition according to claim 8 , wherein Ris chosen from alkyl and aryl claim 8 , each optionally substituted with 0 claim 8 , 1 or multiple R claim 8 , and Ris chosen from hydrogen claim 8 , alkyl claim 8 , aryl claim 8 , and acyl claim 8 , each optionally substituted with 0 claim 8 , 1 or multiple R.12. A composition according to claim 11 , wherein Ris chosen from —CH claim 11 , —CHOCHCH claim 11 , and —CHCHOCH.13. A composition for the control of a fungal pathogen including at least one of the compositions of and a ...

Подробнее
02-07-2015 дата публикации

MACROCYCLIC PICOLINAMIDES AS FUNGICIDES

Номер: US20150181869A1
Принадлежит:

The invention relates to macrocyclic picolinamides of Formula I and their use as fungicides. 2. A compound according to claim 1 , wherein X and Y are hydrogen.3. A compound according to claim 2 , wherein Ris chosen from alkyl and aryl claim 2 , each optionally substituted with 0 claim 2 , 1 or multiple R.4. A compound according to claim 2 , wherein Ris chosen from hydrogen claim 2 , alkyl claim 2 , aryl claim 2 , and acyl claim 2 , each optionally substituted with 0 claim 2 , 1 or multiple R.5. A compound according to claim 2 , wherein Ris chosen from alkyl and aryl claim 2 , each optionally substituted with 0 claim 2 , 1 or multiple R claim 2 , and Ris chosen from hydrogen claim 2 , alkyl claim 2 , aryl claim 2 , and acyl claim 2 , each optionally substituted with 0 claim 2 , 1 or multiple R.6. A compound according to claim 1 , wherein X is C(O)Rand Y is hydrogen.7. A compound according to claim 6 , wherein Ris chosen from alkyl and aryl claim 6 , each optionally substituted with 0 claim 6 , 1 or multiple R.8. A compound according to claim 6 , wherein Ris chosen from hydrogen claim 6 , alkyl claim 6 , aryl claim 6 , and acyl claim 6 , each optionally substituted with 0 claim 6 , 1 or multiple R.9. A compound according to claim 6 , wherein Ris chosen from alkyl and aryl claim 6 , each optionally substituted with 0 claim 6 , 1 or multiple R claim 6 , and Ris chosen from hydrogen claim 6 , alkyl claim 6 , aryl claim 6 , and acyl claim 6 , each optionally substituted with 0 claim 6 , 1 or multiple R.10. A compound according to claim 1 , wherein X is hydrogen and Y is Q.11. A compound according to claim 10 , wherein Ris hydrogen.12. A compound according to claim 11 , wherein Ris chosen from alkyl and aryl claim 11 , each optionally substituted with 0 claim 11 , 1 or multiple R.13. A compound according to claim 11 , wherein Ris chosen from hydrogen claim 11 , alkyl claim 11 , aryl claim 11 , and acyl claim 11 , each optionally substituted with 0 claim 11 , 1 or multiple ...

Подробнее
18-09-2014 дата публикации

MACROCYCLIC PICOLINAMIDES AS FUNGICIDES

Номер: US20140275171A1
Принадлежит:

The invention relates to macrocyclic picolinamides of Formula I and their use as fungicides. 2. A compound according to claim 1 , wherein:{'sub': '6', 'wherein, R is H, or C(O)R;'}{'sub': 1', '6, 'Ris C(O)R;'}{'sub': 2', '5, 'Ris independently or separately H, alkyl, alkenyl, aryl, each substituted with 0, 1 or multiple R;'}{'sub': '3', 'Ris independently or separately H, methyl;'}{'sub': '5', 'Ris alkyl, alkoxy, halo, haloalkyl, or aryl; and'}{'sub': '6', 'Ris alkoxy, or benzyloxy.'}5Mycosphaerella graminicolaSeptoria triticiPuccinia triticinaPuccinia striiformisVenturia inaequalisUstilago maydisUncinula necatorRhynchosporium secalisMagnaporthe griseaPseudoperonospora cubensisPhakopsora pachyrhiziLeptosphaeria nodorumBlumeria graministriticiBlumeria graminishordeiErysiphe cichoracearumGlomerella lagenariumCercospora beticolaAlternaria solaniPyrenophora teres. The compositions according to claim 4 , wherein the plant pathogen is least one pathogen selected from the group consisting of: Leaf Blotch of Wheat ( claim 4 , anamorph: ) claim 4 , Wheat Brown Rust () claim 4 , Stripe Rust () claim 4 , Scab of Apple () claim 4 , Blister Smut of Maize () claim 4 , Powdery Mildew of Grapevine () claim 4 , Barley scald () claim 4 , Blast of Rice () claim 4 , Downy Mildew of Cucurbits () claim 4 , Rust of Soybean () claim 4 , Glume Blotch of Wheat () claim 4 , Powdery Mildew of Wheat (f. sp. ) claim 4 , Powdery Mildew of Barley (f. sp. ) claim 4 , Powdery Mildew of Cucurbits () claim 4 , Anthracnose of Cucurbits () claim 4 , Leaf Spot of Beet () claim 4 , Early Blight of Tomato () claim 4 , and Net Blotch of Barley ().6Septoria triticiPuccinia triticinaPhakopsora pachyrhizi. The composition according to claim 5 , wherein the fungal pathogen is at least one of Leaf Blotch of Wheat () claim 5 , Wheat Brown Rust () claim 5 , and Rust of Soybean ().8. The method according to claim 7 , wherein the compound is applied in a mixture with at least one additional compound selected from ...

Подробнее
15-07-2021 дата публикации

LONG WAVELENGTH EMITTING CHEMILUMINESCENT PROBES

Номер: US20210214607A1
Принадлежит:

Improved long wavelength-emitting chemiluminescent probes are easy to synthesize and are well-suited for both in vitro and in vivo applications, but are particularly well-suited for in vivo applications. The wavelengths of the emissions of the probes include those in the orange, red or NIR range. Dioxetane compounds and phenolic ester compounds are included. 121.-. (canceled)29. A composition comprising a compound according to and a carrier.30. A ready-to-use injectable solution comprising a compound according to .31. A method for determining the presence claim 22 , or measuring the level claim 22 , of an analyte in a sample claim 22 , the method comprising the following steps:{'claim-ref': {'@idref': 'CLM-00022', 'claim 22'}, '(a) contacting the sample with a compound according to , wherein upon exposure to said analyte, said compound reacts with said analyte thereby converting said compound into an emissive species; and'}(b) detecting the emission of said emissive species.32. A biomolecule characterized in that it is bound to a compound of as a label.33. The biomolecule of claim 32 , selected from the group consisting of an antibody claim 32 , a nucleic acid claim 32 , and a protein.34. The method of claim 31 , wherein the analyte is singlet oxygen claim 31 , and the compound is a compound of the Formula Ib.35. The method of claim 31 , wherein the sample is a biological sample.36. The method of claim 35 , wherein the biological sample is a bodily fluid claim 35 , a bodily-based solution claim 35 , or a tissue biopsy sample.37. The method of claim 31 , wherein the method is an in vitro method. The present invention relates to long wavelength emitting probes, in particular to compounds of Formulae Ia, Ib and II, and their applications.Optical imaging modalities have become powerful tools for noninvasive visualization of biomolecular systems and whole body (e.g. animals or human) in real-time with high spatial resolution. Moreover, imaging systems are relatively ...

Подробнее
15-07-2021 дата публикации

Dioxetane compounds and their use for the detection of microorganisms

Номер: US20210214766A1

Dioxetane compounds can be used in the detection of presence or absence, quantification and identification of microorganisms including bacteria, bacterial fragments (e.g., LPS, endotoxin), viruses, fungi as well as other pathogens by means of chemiluminescence and to corresponding methods. A method for the detection of a target analyte, a target microorganism or a target metabolite includes providing a medium including one or more target analytes, target microorganisms or target metabolites, adding a dioxetane compound to the medium so that the compound emits light, and detecting the emitted light.

Подробнее
22-07-2021 дата публикации

ELECTROLYTIC SOLUTION FOR LITHIUM-ION SECONDARY BATTERY, AND LITHIUM-ION SECONDARY BATTERY

Номер: US20210226253A1
Принадлежит:

A lithium-ion secondary battery includes a positive electrode, a negative electrode, and an electrolytic solution. The electrolytic solution includes a solvent, an electrolyte salt, and at least one of a first dioxane compound or a second dioxane compound. 2. The lithium-ion secondary battery according to claim 1 , whereinthe monovalent hydrocarbon group includes one of an alkyl group, an alkenyl group, and an alkynyl group, and has carbon number of less than or equal to 4, andthe divalent hydrocarbon group includes one of an alkylene group, an alkenylene group, and an alkynylene group, and has carbon number of less than or equal to 4.3. The lithium-ion secondary battery according to claim 1 , whereina content of the first dioxane compound in the electrolytic solution is from 0.001 weight percent to 5 weight percent, anda content of the second dioxane compound in the electrolytic solution is from 0.001 weight percent to 5 weight percent.4. The lithium-ion secondary battery according to claim 2 , whereina content of the first dioxane compound in the electrolytic solution is from 0.001 weight percent to 5 weight percent, anda content of the second dioxane compound in the electrolytic solution is from 0.001 weight percent to 5 weight percent.5. The lithium-ion secondary battery according to claim 1 , whereinthe solvent includes at least one of an unsaturated cyclic carbonate ester, a halogenated carbonate ester, or a dinitrile compound, and{'sub': 4', '2', '2', '4', '8, 'the electrolyte salt includes at least one of lithium tetrafluoroborate (LiBF), lithium difluorophosphate (LiPFO), or lithium bis(oxalato)borate (LiCBO).'}6. The lithium-ion secondary battery according to claim 2 , whereinthe solvent includes at least one of an unsaturated cyclic carbonate ester, a halogenated carbonate ester, or a dinitrile compound, and{'sub': 4', '2', '2', '4', '8, 'the electrolyte salt includes at least one of lithium tetrafluoroborate (LiBF), lithium difluorophosphate (LiPFO), or ...

Подробнее
30-08-2018 дата публикации

MACROCYCLIC PICOLINAMIDES AS FUNGICIDES

Номер: US20180242582A1
Принадлежит:

This disclosure relates to macrocyclic picolinamides of Formula I and their use as fungicides. 2. The compound according to claim 1 , wherein X and Y are hydrogen.3. The compound according to claim 1 , wherein X is C(O)Rand Y is hydrogen.48.-. (canceled)9. A composition for the control of a fungal pathogen including at least one of the compounds of and at least one additional compound selected from the group consisting of: a phytologically acceptable carrier material claim 1 , a second fungicide claim 1 , an insecticide claim 1 , a nematocides claim 1 , a miticide claim 1 , an arthropodicide claim 1 , a bactericide.10. The composition for the control of a fungal pathogen according to claim 9 , wherein the at least one additional compound is at least one phytologically acceptable carrier material.11Mycosphaerella graminicolaSeptoria triticiPuccinia triticinaPuccinia striiformisVenturia inaequalisUstilago maydisUncinula necatorRhynchosporium secalisMagnaporthe griseaPhakopsora pachyrhiziLeptosphaeria nodorumBlumeria graministriticiBlumeria graminishordeiErysiphe cichoracearumGlomerella lagenariumCercospora beticolaAlternaria solaniPyrenophora teres. The compositions according to claim 9 , wherein the fungal pathogen is at least one pathogen selected from the group consisting of: Leaf Blotch of Wheat (; anamorph: ) claim 9 , Wheat Brown Rust () claim 9 , Stripe Rust () claim 9 , Scab of Apple () claim 9 , Blister Smut of Maize () claim 9 , Powdery Mildew of Grapevine () claim 9 , Barley Scald () claim 9 , Blast of Rice () claim 9 , Rust of Soybean () claim 9 , Glume Blotch of Wheat () claim 9 , Powdery Mildew of Wheat (f sp. ) claim 9 , Powdery Mildew of Barley (f. sp. ) claim 9 , Powdery Mildew of Cucurbits () claim 9 , Anthracnose of Cucurbits () claim 9 , Leaf Spot of Beet () claim 9 , Early Blight of Tomato () claim 9 , and Net Blotch of Barley ().12Septoria triticiPuccinia triticinaPhakopsora pachyrhizi. The composition according to wherein the fungal pathogen is ...

Подробнее
30-07-2020 дата публикации

CHEMILUMINESCENT PROBES FOR DIAGNOSTICS AND IN VIVO IMAGING

Номер: US20200237932A1
Принадлежит:

The present invention provides dioxetane-based chemiluminescence probes, more specifically fluorophore-tethered dioxetane-based chemiluminescence probes and compositions thereof. The chemiluminescence probes disclosed are useful for both diagnostics and in vivo imaging. 2. The compound of claim 1 , wherein:{'sup': '1', 'sub': 1', '8, '(i) Ris a linear or branched (C-C)alkyl; or'}{'sup': 2', '3, '(ii) Rand Rtogether with the carbon atom to which they are attached form a fused, spiro or bridged polycyclic ring; or'}{'sup': 5', '6, 'sub': 1', '8, '(iii) Rand Reach independently is (C-C)alkyl, and together with the oxygen atoms to which they are attached form a heterocyclic ring; or'}{'sup': 7', '8', '9', '7', '8', '9, 'sub': '2', '(iv) at least one of R, Rand Ris H, and the other of R, Rand Reach independently is an electron acceptor group selected from the group consisting of halogen, —NOand —CN; or'}{'sub': 3', '2', '3', '3', '3', '2', '2, '(v) said protecting group is selected from the group consisting of —CH, —CHOCH, —C(═O)C(CH), —CH—CH═CH, TBDMS, TBDPS, benzyl, and 2-nitro-4,5-dimethoxybenzyl.'}3. The compound of claim 2 , wherein Rand Rtogether with the carbon atom to which they are attached form adamantyl.4. The compound of claim 2 , wherein Rand Reach is isopropyl and together with the oxygen atoms to which they are attached form 4 claim 2 ,4 claim 2 ,5 claim 2 ,5-tetramethyl-1 claim 2 ,3 claim 2 ,2-dioxaborolanyl.5. The compound of claim 1 , wherein:{'sup': '1', 'sub': 1', '8, 'Ris a linear or branched (C-C)alkyl;'}{'sup': 2', '3, 'Rand Rtogether with the carbon atom to which they are attached form a fused, spiro or bridged polycyclic ring;'}{'sup': 5', '6, 'sub': 1', '8, 'Rand Reach independently is (C-C)alkyl, and together with the oxygen atoms to which they are attached form a heterocyclic ring; and'}{'sup': 7', '8', '9', '7', '8', '9, 'sub': '2', 'at least one of R, Rand Ris H, and the other of R, Rand Reach independently is an electron acceptor group ...

Подробнее
06-08-2020 дата публикации

Prodrug and profluorescent compounds for selective mitochondrial imaging and therapeutic targeting

Номер: US20200247775A1
Принадлежит: Arizona Board of Regents of ASU

The present invention relates to the use of prodrugs susceptible to nitroreductase (NTR) activation. In particular, provided herein are mitochondria-targeting prodrug compounds and probes, including profluorescent near-infrared (NIR) probes and non-fluorescent prodrugs, as well as to methods of using said prodrug compounds and probes for imaging mitochondria and for mitochondria-specific delivery of therapeutic agents.

Подробнее
01-10-2015 дата публикации

Highly active multidentate catalysts for efficient alkyne metathesis

Номер: US20150273457A1
Принадлежит: University of Colorado

The invention relates to highly active and selective catalysts for alkyne metathesis. In one aspect, the invention includes a multidentate organic ligand wherein one substrate-binding site of the metal center is blocked. In another aspect, the invention includes N-quaternized or silane-based multidentate organic ligands, capable of binding to metals. In yet another aspect, the invention includes N-quaternized or silane-based multidentate catalysts. The catalysts of the invention show high robustness, strong resistance to small alkyne polymerization and significantly enhanced catalytic activity compared to their corresponding non-quaternized or non-silane-based multidentate catalyst analogues.

Подробнее
28-09-2017 дата публикации

MACROCYCLIC PICOLINAMIDES AS FUNGICIDES

Номер: US20170273303A1
Принадлежит:

This disclosure relates to macrocyclic picolinamides of Formula I and their use as fungicides. 2. The compound according to claim 1 , wherein X and Y are hydrogen.3. The compound according to claim 2 , wherein Ris alkyl or aryl claim 2 , each optionally substituted with 0 claim 2 , 1 or multiple R.4. The compound according to claim 2 , wherein Ris hydrogen or alkyl claim 2 , each optionally substituted with 0 claim 2 , 1 or multiple R.5. The compound according to claim 1 , wherein X is C(O)Rand Y is hydrogen.6. The compound according to claim 5 , wherein Ris alkyl or aryl claim 5 , each optionally substituted with 0 claim 5 , 1 or multiple R.7. The compound according to claim 5 , wherein Ris hydrogen or alkyl claim 5 , each optionally substituted with 0 claim 5 , 1 or multiple R.8. The compound according to claim 1 , wherein X is hydrogen and Y is Q.9. The compound according to claim 8 , wherein Ris alkyl or aryl claim 8 , each optionally substituted with 0 claim 8 , 1 or multiple R.10. The compound according to claim 8 , wherein Ris hydrogen or alkyl claim 8 , each optionally substituted with 0 claim 8 , 1 or multiple R.11. The compound according to claim 9 , wherein Ris hydrogen.12. The compound according to claim 9 , wherein Ris —C(O)R or —CHOC(O)R.13. The compound according to claim 12 , wherein Ris alkyl or alkoxy claim 12 , each optionally substituted with 0 claim 12 , 1 claim 12 , or multiple R.14. The compound according to claim 13 , wherein Ris —CH claim 13 , —CH(CH) claim 13 , —CHOCHCH claim 13 , or —CHCHOCH.15. A composition for the control of a fungal pathogen including at least one of the compounds of Formula I and at least one additional compound selected from the group consisting of: a phytologically acceptable carrier material claim 13 , a second fungicide claim 13 , an insecticide claim 13 , a nematocide claim 13 , a miticide claim 13 , an arthropodicide claim 13 , and a bactericide.16. The composition according to claim 15 , wherein the least one ...

Подробнее
20-08-2020 дата публикации

Compounds for inhibiting bacterial growth via phosphatidylglycerol binding

Номер: US20200261415A1
Принадлежит: Wichita State University

Antibacterial small molecule compounds, termed liptins, bind to phosphatidylglycerol in bacterial plasma membranes. The small molecule compounds comprise a three-dimensional complementary binding pocket for phosphatidylglycerol, disrupting membrane function in a bacteriostatic or bactericidal manner. Methods of inhibiting bacterial growth and/or treating Gram-positive or Gram-negative bacterial infection using such compounds are also disclosed.

Подробнее
26-09-2019 дата публикации

Chemiluminescent probes for diagnostics and in vivo imaging

Номер: US20190290787A1
Принадлежит: Ramot at Tel Aviv University Ltd

Dioxetane-based chemiluminescence probes, more specifically fluorophore-tethered dioxetane-based chemiluminescence probes and π* acceptor group-containing dioxetane based chemiluminescence probes can be included in compositions. The chemiluminescence probes are useful for both diagnostics and in vivo imaging.

Подробнее
26-09-2019 дата публикации

TREPROSTINIL DERIVATIVE COMPOUNDS AND METHODS OF USING SAME

Номер: US20190292163A1
Принадлежит:

Compounds represented by formulae I, II, III, and IV including pro-drugs for treprostinil and prostacyclin analogs. Uses include treatment of pulmonary hypertension (PH) or pulmonary arterial hypertension (PAH). The structures of the compounds can be adapted to the particular application for a suitable treatment dosage. Transdermal applications can be used. 170-. (canceled)72. The compound of claim 71 , wherein Ris Pand Ris H.73. The compound of claim 71 , wherein Ris H and Ris P.74. The compound of claim 71 , wherein Ris Pand Ris P.75. The compound of claim 71 , wherein each of Rto Ris H.76. The compound of claim 71 , wherein at least one of Rto Ris deuterium.77. The compound of claim 71 , wherein Z is —OR.78. The compound of claim 71 , wherein Z is P.79. The compound of claim 71 , wherein Z is —N(R)R.80. The compound of claim 71 , wherein Z is —OH.82. A composition comprising a compound of or a pharmaceutically acceptable salt thereof and at least one other component.83. The composition of claim 82 , which is formulated for transdermal delivery.84. The composition of claim 83 , which is formulated for transdermal delivery with a patch.85. The composition of claim 82 , further comprising at least one solvent.86. A method of treating pulmonary hypertension claim 71 , comprising administering to a subject in need of treatment a therapeutically effective amount of a compound of or a pharmaceutically acceptable salt thereof.87. The method of claim 86 , wherein the pulmonary hypertension is pulmonary arterial hypertension.88. The method of claim 86 , wherein the compound is administered transdermally.89. The method of claim 88 , wherein the compound is administered via a transdermal patch. This application claims priority to U.S. provisional application 61/751,608 filed Jan. 11, 2013 which is incorporated herein by reference in its entirety for all purposes.Pulmonary hypertension (PH) or pulmonary arterial hypertension (PAH) is a disease which can result in death and is ...

Подробнее
18-10-2018 дата публикации

In Situ Chemiluminescent Substrates and Assays

Номер: US20180299456A1
Принадлежит:

Methods for generating a chemiluminescent enzyme substrate in situ, in aqueous or other assay conditions. Also disclosed are methods to use the substrates to generate light, detect and/or quantify enzymes, antigens, and/or nucleic acids. Kits relating to these methods are also disclosed. 2. The method of claim 1 , wherein the oxidant is selected from hydrogen peroxide claim 1 , sodium molybdate claim 1 , hydrogen peroxide and sodium molybdate claim 1 , hypochlorite claim 1 , hypochlorite and hydrogen peroxide claim 1 , aryl endoperoxide claim 1 , calcium peroxide peroxyhydrate claim 1 , and combinations thereof.3. The method of claim 2 , wherein the oxidant is hydrogen peroxide claim 2 , and hydrogen peroxide and sodium molybdate.6. The method of claim 1 , wherein Ris alkyl containing 1 to 2 carbon atoms or trifluoalkyl containing 1 to 2 carbon atoms.12. The method of claim 1 , wherein the enzyme moiety comprises a hydrolytic enzyme.13. The method of claim 12 , wherein the hydrolyic enzyme is alkaline phosphatase claim 12 , β-galactosidase claim 12 , β-glucosidase claim 12 , β-glucuronidase claim 12 , or neuraminidase.14. The method of claim 13 , wherein the enzyme moiety is an enzyme.15. The method of claim 14 , further comprising the step of detecting the light emitted from the reaction mixture after addition of the aqueous solution of the 1 claim 14 ,2-dioxetane enzyme substrate claim 14 , wherein the emission of light is indicative of the presence of the enzyme claim 14 , and the amount of light emitted can be correlated to the amount of the enzyme present in the sample.16. The method of claim 13 , wherein the enzyme moiety is an enzyme-linked antibody comprising a first antibody capable of binding to an antigen and an enzyme capable of cleaving the 1 claim 13 ,2-dioxetane enzyme substrate so that the substrate decomposes and generates light.17. The method of claim 16 , wherein the first antibody is covalently or non-covalently linked to the enzyme.18. The ...

Подробнее
03-11-2016 дата публикации

BROMINE-SENSITIZED SOLAR PHOTOLYSIS OF CARBON DIOXIDE

Номер: US20160319423A1
Автор: BRAIMAN Mark S.
Принадлежит:

There is described a process for depositing carbon on a surface, comprising, while contacting a mixture of COand Brwith a polar substrate presenting apposed surfaces, exposing a sufficient area of said mixture in the region of said apposed surfaces to light of sufficient intensity and frequency to result in deposition of carbon on at least some of said apposed surfaces. Other embodiments are also described. 119-. (canceled)20. A composition of matter comprising a polar substrate presenting apposed surfaces and a mixture of COand Brin contact with at least some of said apposed surfaces.21. A composition of matter according to claim 20 , wherein said polar substrate is a non-carbonaceous polar substrate.22. A composition of matter according to claim 21 , wherein said polar substrate is selected from the group consisting of silica claim 21 , silica-based glasses claim 21 , alumina and titania claim 21 , and mixtures thereof.23. A composition of matter according to claim 22 , wherein said polar substrate is in particulate form.24. A composition of matter according to claim 22 , wherein said polar substrate is selected from sand claim 22 , silica gel claim 22 , powdered alumina claim 22 , titania claim 22 , quartz sand claim 22 , glass spheres claim 22 , and glass wool.25. A composition of matter according to claim 20 , wherein the polar substrate claim 20 , COand Brand are contained in a UV and visible-light transparent region of a reaction vessel.26. A composition of matter according to claim 25 , wherein said UV and visible-light transparent region is transparent to light having a wavelength of 300 to 500 nm.27. A composition of matter according to claim 25 , wherein said UV-light transparent region is also transparent to visible light.28. A composition of matter according to any of wherein the reaction vessel is made from quartz or borosilicate glass.2937-. (canceled)38. A reactor for utilizing solar energy and bromine to reduce CO claim 25 , the reactor comprising a ...

Подробнее
12-11-2015 дата публикации

LOW CATALYST LOADING IN METATHESIS REACTIONS

Номер: US20150322079A1
Автор: Kadyrov Renat
Принадлежит: Evonik Industries AG

The present invention relates to a method for producing metathesis products comprising contacting metathesis starting materials under metathesis conditions with a metathesis catalyst, wherein the metathesis catalyst is employed in an amount of from 0.0001 mol-% to 1 mol-% based on half of the sum of the reactive double bonds of the metathesis starting materials and wherein the ethylene or propylene generated in the course of the reaction is removed from the reaction mixture. 1. Method for producing metathesis products comprising contacting metathesis starting materials under metathesis conditions with a metathesis catalyst , wherein the metathesis catalyst is employed in an amount of from 0.0001 mol-% to 1 mol-% based on half of the sum of the reactive double bonds of the metathesis starting materials and wherein the ethylene or propylene generated in the course of the reaction is removed from the reaction mixture.3. Method according to claim 2 , wherein the metathesis catalyst is a ruthenium catalyst of general formula 3.5. Method according to claim 1 , wherein ethylene or propylene are removed from the reaction mixture by volatilization.6. Method according to claim 5 , wherein the reaction mixture is sparged with inert gas to remove ethylene or propylene.7. Method according to claim 6 , wherein the reaction mixture is continuously sparged with inert gas to remove ethylene or propylene.8. Method according to claim 1 , wherein the metathesis starting materials are olefinic compounds having at least one reactive double bond in the form of an α-olefin and/or β-olefin claim 1 , with the proviso that not more than one β-olefin is present in the same molecule.9. Method according to claim 1 , wherein the metathesis starting material is an olefinic compound having two reactive double bonds in the form of two α-olefins or one α-olefin and one β-olefin.10. Method according to claim 1 , wherein the metathesis starting materials are olefinic compounds having at least one ...

Подробнее
10-10-2019 дата публикации

LIGHT GENERATING MICROCAPSULES FOR SELF-HEALING POLYMER APPLICATIONS

Номер: US20190309105A1
Принадлежит:

A self-healing polymeric material includes a polymeric matrix material, wherein dispersed within the polymeric matrix material is a mixture of materials that includes monomers and a photoinitiator, and a plurality of light generating microcapsules dispersed in the polymeric matrix material. Each light generating microcapsule encapsulates multiple reactants that undergo a chemiluminescent reaction. The chemiluminescent reaction generates a photon having a wavelength within a particular emission range that is consistent with an absorption range of the photoinitiator. 1. A self-healing polymeric material comprising:a polymeric matrix material;wherein dispersed within the polymeric matrix material is a mixture of materials that includes monomers and a photoinitiator; anda plurality of light generating microcapsules dispersed in the polymeric matrix material, each light generating microcapsule of the plurality of light generating microcapsules encapsulating multiple reactants that undergo a chemiluminescent reaction, wherein each light generating microcapsule comprises an outer shell and an inner shell,wherein the chemiluminescent reaction generates a photon having a wavelength within a particular emission range that is consistent with an absorption range of the photoinitiator and wherein the chemiluminescent reaction occurs without rupture of the outer shell of the light generating microcapsules.2. The self-healing polymeric material of claim 1 , wherein a crack in the polymeric matrix material causes migration of the monomers and photoinitiator into the crack.3. The self-healing polymeric material of claim 2 , wherein further propagation of the crack in the polymeric matrix material results in application of a compressive force to a light generating microcapsule of the plurality of light generating microcapsules claim 2 , the compressive force triggering the chemiluminescent reaction within the light generating microcapsule.4. The self-healing polymeric material of ...

Подробнее
09-11-2017 дата публикации

Flash and Glow 1,2-Dioxetanes

Номер: US20170321245A1
Принадлежит:

Compounds having chemiluminescent flash and glow properties. Also disclosed are methods using the compounds to generate light, detect and/or quantify enzymes, antigens, and/or nucleic acids. Also disclosed are kits relating to these compounds. 193.-. (canceled)951. The compound of claim , wherein the cleavage of the bond cleavable by an enzyme moiety results in the generation of light at 37° C. which reaches a maximum in less than about 5 minutes.961. The compound of claim , wherein the cleavage of the bond cleavable by an enzyme moiety results in the generation of light at 37° C. which reaches a maximum in 3 minutes or less.100. A method for generating light , comprising the steps of:{'b': '1', '(a) providing a compound of claim ;'}(b) providing an enzyme complex comprising an enzyme moiety which is capable of cleaving the compound;(c) contacting the enzyme complex with the compound to form a reaction mixture; and,(d) allowing the reaction mixture to generate light.101. The method of claim 100 , wherein the cleavage of the bond cleavable by the enzyme moiety results in the generation of light at 37° C. which reaches a maximum in 3 minutes or less.105. The method of claim 100 , wherein the compound has a constant signal-to-noise ratio.106. The method of claim 100 , wherein the compound has improved sensitivity claim 100 , wherein sensitivity is defined as the lowest amount of hIL-6 detect at a signal-to-noise of 2.107. The method of claim 100 , wherein the enzyme moiety is a hydrolytic enzyme chosen from alkaline phosphatase claim 100 , β-galactosidase claim 100 , β-glucosidase claim 100 , β-glucuronidase claim 100 , or neuraminidase.108. A method for determining the presence and/or amount of an enzyme in a sample claim 100 , comprising the steps of:{'b': '1', '(a) providing a compound of claim ;'}(b) providing a sample suspected of comprising the enzyme which is capable of cleaving the compound so that it decomposes and generates light;(c) contacting the sample ...

Подробнее
23-11-2017 дата публикации

Macrocyclic picolinamides as fungicides

Номер: US20170334934A1
Принадлежит: DOW AGROSCIENCES LLC

This disclosure relates to macrocyclic picolinamides of Formula I and their use as fungicides. 2. A compound according to claim 1 , wherein X and Y are hydrogen.3. A compound according to claim 2 , wherein Ris alkyl claim 2 , aryl claim 2 , or acyl each optionally substituted with 0 claim 2 , 1 or multiple R.4. A compound according to claim 2 , wherein Ris chosen from —(CH)Rwhere n is an integer between 0 and 4 and Ris hydrogen or alkyl claim 2 , optionally substituted with 0 claim 2 , 1 or multiple R.5. A compound according to claim 1 , wherein X is C(O)Rand Y is hydrogen.6. A compound according to claim 5 , wherein Ris chosen from hydrogen claim 5 , alkyl claim 5 , aryl claim 5 , acyl claim 5 , or silyl each optionally substituted with 0 claim 5 , 1 or multiple R.7. A compound according to claim 5 , wherein Ris chosen from —(CH)Rwhere n is an integer between 0 and 4 and Ris hydrogen or alkyl claim 5 , optionally substituted with 0 claim 5 , 1 or multiple R.8. A compound according to claim 1 , wherein X is hydrogen and Y is Q.9. A compound according to claim 8 , wherein Ris chosen from alkyl claim 8 , aryl claim 8 , or acyl each optionally substituted with 0 claim 8 , 1 or multiple R.10. A compound according to claim 8 , wherein Ris chosen from —(CH)Rwhere n is an integer between 0 and 4 and Ris hydrogen or alkyl claim 8 , optionally substituted with 0 claim 8 , 1 or multiple R.11. A compound according to and claim 8 , wherein Ris hydrogen.12. A compound according to and claim 8 , wherein Ris —C(O)Ror —CHOC(O)R.13. A compound according to claim 12 , wherein Ris chosen from alkyl or alkoxy claim 12 , each optionally substituted with 0 claim 12 , 1 claim 12 , or multiple R.14. A compound according to claim 13 , wherein Ris chosen from —CHor —CH(CH).15. A composition for the control of a fungal pathogen including at least one of the compounds of - and a phytologically acceptable carrier material.16. A composition for the control of a fungal pathogen including mixtures ...

Подробнее
31-10-2019 дата публикации

Prodrug and profluorescent compounds for selective mitochondrial imaging and therapeutic targeting

Номер: US20190330176A1
Принадлежит: Arizona Board of Regents of ASU

The present invention relates to the use of prodrugs susceptible to nitroreductase (NTR) activation. In particular, provided herein are mitochondria-targeting prodrug compounds and probes, including profluore scent near-infrared (NIR) probes and non-fluorescent prodrugs, as well as to methods of using said prodrug compounds and probes for imaging mitochondria and for mitochondria-specific delivery of therapeutic agents.

Подробнее
07-12-2017 дата публикации

CONDENSED HETEROCYCLIC COMPOUND

Номер: US20170349605A1
Принадлежит: Takeda Pharmaceutical Company Limited

The present invention relates to a condensed heterocyclic compound that has an enteropeptidase inhibitory effect and is useful in the treatment or prevention of obesity, diabetes mellitus, or the like, and a medicament containing the same. Specifically, the present invention relates to a compound represented by the following formula (I) or a salt thereof, and a medicament containing the same [in the formula, each symbol is as defined in the specification]. 2. The compound according to or a salt thereof claim 1 , wherein [ 1) a halogen atom,', '2) a carboxy group,', '3) a cyano group,', {'sub': 6-14', '1-6', '1-6, '4) a carbamoyl group optionally substituted by a Caryl group optionally substituted by 1 to 3 substituents selected from a sulfo group; and a Calkyl group optionally substituted by a mono- or di-Calkylphosphono group,'}, {'sub': '1-6', '5) 3- to 14-membered nonaromatic heterocyclylcarbonyl optionally substituted by 1 to 3 substituents selected from a carboxy group; and/or a mono- or di-Calkyl-carbamoyl group substituted by 1 or 2 carboxy groups,'}, {'sub': '1-6', '6) a 3- to 14-membered nonaromatic heterocyclic group optionally substituted by 1 to 3 substituents selected from a Calkyl group substituted by 1 or 2 carboxy groups; and a carboxy group,'}, {'sub': 1-6', '1-6', '1-6, '7) a Calkyl group optionally substituted by 1 to 3 substituents selected from a mono- or di-Calkyl-carbamoyl group substituted by 1 to 3 substituents selected from a carboxy group, a hydroxy-phenyl group, and a carbamoyl group; a Calkoxy-carbonyl group; and a carboxy group,'}, {'sub': 1-6', '1-6, '8) a Calkoxy group optionally substituted by a mono- or di-Calkyl-carbamoyl group substituted by 1 or 2 carboxy groups,'}, {'sub': '1-6', 'claim-text': (a) a carboxy group;', '(b) a sulfo group;', '(c) a hydroxy group;', {'sub': '1-6', '(d) a Calkoxy group optionally substituted by a phenyl group;'}, {'sub': '1-6', '(e) a Calkoxy-carbonyl group;'}, '(f) a guanidino group;', {'sub': '6-14 ...

Подробнее
07-11-2019 дата публикации

Organic Materials with Special Optical Effects

Номер: US20190337885A1

The present invention relates to a compound of the following formula (I). The invention also relates to uses thereof as a chromophore as such or for building pigments displaying special optical effects, including metal-like reflection.

Подробнее
15-12-2016 дата публикации

CHEMILUMINESCENT METHODS AND REAGENTS FOR ANALYTE DETECTION

Номер: US20160362388A1
Автор: LI Xingxiang, Wang Tianxin
Принадлежит:

The present invention relates to chemiluminescent method and regent to detect analyte. One aspect of the current invention relates to using enzyme substrate that can be cleaved by target enzyme to release chemiluminescent compound giving light signal for the detection of varieties of target enzymes. Another aspect of the current invention relates to use chemiluminescent enzyme coupled with analyte binding molecules to detect specific analyte molecules in a homogenous phase. 2. A method to detecting analyte in a sample , comprising:a) contacting said sample with a first ligand of the analyte coupled with ATP producing enzyme and a second ligand of the analyte coupled with luciferase, wherein said luciferase use ATP as substrate; andb) detecting the light generated from said luciferase.3. A kit for detecting analyte in a sample , comprising a first ligand of the analyte coupled with ATP producing enzyme and a second ligand of the analyte coupled with luciferase. This application is the divisional application of U.S. application Ser. No. 12/287,916 filed on Oct. 15, 2008, which claims priority to U.S. Provisional Application No. 60/999,166 filed on Oct. 16, 2007. The entire disclosure of the prior application is considered to be part of the disclosure of the instant application and is hereby incorporated by reference.The present invention relates to chemiluminescent method and regent to detect analyte. One aspect of the current invention relates to using enzyme substrate that can be cleaved by target enzyme to release chemiluminescent compound giving light signal for the detection of varieties of target enzymes. Another aspect of the current invention relates to using chemiluminescent enzyme coupled with analyte binding molecules to detect specific analyte molecules in a homogenous phase.Advances in the biological, biomedical and pharmaceutical sciences have accelerated the pace of research and diagnostics to a level unparalleled to the past. With sequences of whole ...

Подробнее
22-12-2016 дата публикации

Treprostinil derivative compounds and methods of using same

Номер: US20160368889A1
Принадлежит: Corsair Pharma Inc

Compounds represented by formulae I, II, III, and IV including pro-drugs for treprostinil and prostacyclin analogs. Uses include treatment of pulmonary hypertension (PH) or pulmonary arterial hypertension (PAH). The structures of the compounds can be adapted to the particular application for a suitable treatment dosage. Transdermal applications can be used.

Подробнее
27-12-2018 дата публикации

Chiral Cyclodecynes and Methods

Номер: US20180370943A1
Принадлежит:

Provided herein are cyclodecynes, including chiral cyclodecynes, and methods of making cyclodecynes. The methods may include providing a 1,1′-biaryl compound substituted independently at the 2-position and the 2′-position with a hydroxyl or an amino group; and contacting the 1,1′-biaryl compound with a protected but-2-yne-1,4-diol to form the cyclodecyne. 1. A method of making a cyclodecyne , the method comprising:providing a 1,1′-biaryl compound substituted independently at the 2-position and the 2′-position with a hydroxyl or an amino group; andcontacting the 1,1′-biaryl compound with a protected but-2-yne-1,4-diol to form the cyclodecyne;wherein the amino group comprises a primary amine, a secondary amine, or a tertiary amine.6. The method of claim 1 , wherein the protected but-2-yne-1 claim 1 ,4-diol comprises tosylate protecting groups.7. The method of claim 1 , wherein the protected but-2-yne-1 claim 1 ,4-diol comprises nosylate protecting groups.8. The method of claim 1 , wherein the contacting occurs at ambient temperature and ambient pressure.9. The method of claim 1 , wherein the contacting occurs in the presence of a base.10. The method of claim 9 , wherein the base comprises CsCO.11. The method of claim 1 , wherein the contacting occurs in the presence of CsCO claim 1 , CHCN claim 1 , dimethyl formamide claim 1 , or a combination thereof.12. The method of claim 1 , wherein the cyclodecyne is an (R)-cyclodecyne.13. The method of claim 1 , wherein the cyclodecyne is an (S)-cyclodecyne. This application claims priority to U.S. Provisional Patent Application No. 62/524,743, filed Jun. 26, 2017, which is incorporated herein by reference.Click chemistry has the potential to achieve functional group orthogonality, high yields, and/or other advantages in diverse applications, ranging from surface functionalization to drug delivery. However, the utility of a prototypical click reaction, the Cu-catalyzed alkyne-azide cycloaddition, can be hampered by the toxicity ...

Подробнее
27-12-2018 дата публикации

Light generating microcapsules for self-healing polymer applications

Номер: US20180371122A1
Принадлежит: International Business Machines Corp

A self-healing polymeric material includes a polymeric matrix material, a plurality of monomer mixture microcapsules dispersed in the polymeric matrix material, and a plurality of light generating microcapsules dispersed in the polymeric matrix material. Each monomer mixture microcapsule encapsulates a mixture of materials that includes monomers and a photoinitiator. Each light generating microcapsule encapsulates multiple reactants that undergo a chemiluminescent reaction. The chemiluminescent reaction generates a photon having a wavelength within a particular emission range that is consistent with an absorption range of the photoinitiator.

Подробнее
27-12-2018 дата публикации

LIGHT GENERATING MICROCAPSULES FOR SELF-HEALING POLYMER APPLICATIONS

Номер: US20180371123A1
Принадлежит:

A self-healing polymeric material includes a polymeric matrix material, a plurality of monomer mixture microcapsules dispersed in the polymeric matrix material, and a plurality of light generating microcapsules dispersed in the polymeric matrix material. Each monomer mixture microcapsule encapsulates a mixture of materials that includes monomers and a photoinitiator. Each light generating microcapsule encapsulates multiple reactants that undergo a chemiluminescent reaction. The chemiluminescent reaction generates a photon having a wavelength within a particular emission range that is consistent with an absorption range of the photoinitiator. 110.-. (canceled)11. A process of utilizing chemiluminescence for polymeric self-healing , the process comprising:dispersing a monomer mixture microcapsule in a polymeric matrix material, the monomer mixture microcapsule encapsulating a mixture of materials that includes monomers and a photoinitiator; anddispersing a light generating microcapsule in the polymeric matrix material, the light generating microcapsule encapsulating multiple reactants that undergo a chemiluminescent reaction, wherein the chemiluminescent reaction generates a photon having a wavelength within a particular emission range that is consistent with an absorption range of the photoinitiator,wherein the monomer mixture microcapsule is adapted to rupture to cause migration of the mixture of materials into a crack in the polymeric matrix material, andwherein the light generating microcapsule is adapted to cause the multiple reactants to undergo the chemiluminescent reaction within the light generating microcapsule in response to application of a compressive force.12. The process of claim 11 , wherein the chemiluminescent reaction includes excitation of a dye from a ground state to an excited state and subsequent release of the photon upon relaxation from the excited state to the ground state.13. The process of claim 11 , wherein the light generating ...

Подробнее
10-12-2020 дата публикации

SILICON-BASED ENERGY STORAGE DEVICES WITH ELECTROLYTE ADDITIVE COMPOUNDS

Номер: US20200388880A1
Принадлежит:

Electrolytes and electrolyte additives for energy storage devices are disclosed. The energy storage device comprises a first electrode and a second electrode, where one or both of the first electrode and the second electrode is a Si-based electrode, a separator between the first electrode and the second electrode, an electrolyte, and at least one electrolyte additive compound selected from a carbonate, oxalate, trioxidane, peroxide, peroxoate, dioxetanone, oxepane dione, oxetane dione, anhydride, oxalate or 1,4-dioxane-2,3-dione; each of which may be optionally substituted. 1. An energy storage device comprising:a first electrode and a second electrode, where one or both of the first electrode and the second electrode is a Si-based electrode;a separator between the first electrode and the second electrode;an electrolyte; andat least one electrolyte additive compound comprising a carbonate, oxalate, trioxidane, peroxide, peroxoate, dioxetanone, oxepane dione, oxetane dione, anhydride, oxalate or 1,4-dioxane-2,3-dione; each of which is optionally substituted.2. The energy storage device of claim 1 , wherein the second electrode is a Si-dominant electrode.3. The energy storage device of claim 1 , wherein the second electrode comprises a self-supporting composite material film.4. The energy storage device of claim 3 , wherein the composite material film comprises:greater than 0% and less than about 90% by weight of silicon particles, andgreater than 0% and less than about 90% by weight of one or more types of carbon phases, wherein at least one of the one or more types of carbon phases is a substantially continuous phase that holds the composite material film together such that the silicon particles are distributed throughout the composite material film.5. The energy storage device of claim 1 , wherein the electrolyte further comprises fluoroethylene carbonate (FEC).6. The energy storage device of claim 5 , wherein the electrolyte is substantially free of non-fluorine ...

Подробнее
31-12-2020 дата публикации

TREPROSTINIL DERIVATIVE COMPOUNDS AND METHODS OF USING SAME

Номер: US20200407336A1
Принадлежит: CORSAIR PHARMA, INC.

Compounds represented by formulae I, II, III, and IV including pro-drugs for treprostinil and prostacyclin analogs. Uses include treatment of pulmonary hypertension (PH) or pulmonary arterial hypertension (PAH). The structures of the compounds can be adapted to the particular application for a suitable treatment dosage. Transdermal applications can be used. 170-. (canceled)72. The compound of claim 71 , wherein Ris Pand Ris H.73. The compound of claim 71 , wherein Ris H and Ris P.74. The compound of claim 71 , wherein Ris Pand Ris P.75. The compound of claim 71 , wherein each of Rto Ris H.76. The compound of claim 71 , wherein at least one of Rto Ris deuterium.77. The compound of claim 71 , wherein Z is —OR.78. The compound of claim 71 , wherein Z is P.79. The compound of claim 71 , wherein Z is —N(R)R.80. The compound of claim 71 , wherein Z is −OH.82. A composition comprising a compound of or a pharmaceutically acceptable salt thereof and at least one other component.83. The composition of claim 82 , which is formulated for transdermal delivery.84. The composition of claim 83 , which is formulated for transdermal delivery with a patch.85. The composition of claim 82 , further comprising at least one solvent.86. A method of treating pulmonary hypertension claim 71 , comprising administering to a subject in need of treatment a therapeutically effective amount of a compound of or a pharmaceutically acceptable salt thereof.87. The method of claim 86 , wherein the pulmonary hypertension is pulmonary arterial hypertension.88. The method of claim 86 , wherein the compound is administered transdermally.89. The method of claim 88 , wherein the compound is administered via a transdermal patch. This application claims priority to U.S. provisional application 61/751,608 filed Jan. 11, 2013 which is incorporated herein by reference in its entirety for all purposes.Pulmonary hypertension (PH) or pulmonary arterial hypertension (PAH) is a disease which can result in death and is ...

Подробнее
17-03-2004 дата публикации

Chiral compounds

Номер: GB0403135D0
Автор: [UNK]
Принадлежит: Merck Patent GmBH

Подробнее
08-01-2014 дата публикации

LCD display

Номер: JP5383994B2
Принадлежит: Merck Patent GmBH

Подробнее
16-12-2004 дата публикации

Isolation, formulation and shaping of macrocyclic oligoesters

Номер: US20040254281A1
Принадлежит: Cyclics Corp

Processes for isolating, formulating, and shaping macrocyclic oligesters were developed which allow efficient production of macrocyclic oligoesters substantially free from solvent, which may include additives, fillers, and catalysts.

Подробнее
23-02-2010 дата публикации

Isolation, formulation, and shaping of macrocyclic oligoesters

Номер: US7666517B2
Принадлежит: Cyclics Corp

Processes for isolating, formulating, and shaping macrocyclic oligoesters were developed which allow efficient production of macrocyclic oligoesters substantially free from solvent, which may include additives, fillers, and catalysts.

Подробнее
04-07-2006 дата публикации

Isolation, formulation and shaping of macrocyclic oligoesters

Номер: US7071291B2
Принадлежит: Cyclics Corp

Processes for isolating, formulating, and shaping macrocyclic oligesters were developed which allow efficient production of macrocyclic oligoesters substantially free from solvent, which may include additives, fillers, and catalysts.

Подробнее
12-10-2009 дата публикации

Chiral compounds

Номер: KR100920912B1
Принадлежит: 메르크 파텐트 게엠베하

본 발명은 화학식 I(여기서 X 1 , X 2 , Y 1 , Y 2 , x 1 , x 2 , y 1 , y 2 , B, C, U 1 , U 2 , V 1 , V 2 , W 1 및 W 2 는 청구항 1에서의 정의와 동일하다)의 키랄 화합물; 화학식 I의 키랄 화합물을 하나 이상 포함하는 액정 혼합물; 화학식 I의 키랄 화합물을 하나 이상 포함하는 중합가능한 혼합물을 중합시킴으로써 수득될 수 있는 키랄 선형 또는 가교결합된 액정 중합체; 액정 디스플레이, 능동 및 수동 광학 소자, 접착제, 유전 이방성 기계적 특성을 갖는 합성 수지, 화장품 및 약학 조성물, 진단제, 액정 안료에서, 장식 및 보안 목적을 위해, 비선형 광학 물질, 광학 정보 저장 매체에서, 또는 키랄 도판트로서의 화학식 I의 키랄 화합물 및 혼합물, 및 이들로부터 수득된 중합체의 용도; 및 화학식 I의 키랄 화합물을 하나 이상 포함하는 혼합물을 포함하는 액정 디스플레이에 관한 것이다. The present invention is formula I (where X 1 , X 2 , Y 1 , Y 2 , x 1 , x 2 , y 1 , y 2 , B, C, U 1 , U 2 , V 1 , V 2 , W 1 and W 2 is the same as defined in claim 1); Liquid crystal mixtures comprising at least one chiral compound of formula (I); Chiral linear or crosslinked liquid crystal polymers obtainable by polymerizing a polymerizable mixture comprising at least one chiral compound of formula (I); In liquid crystal displays, active and passive optical devices, adhesives, synthetic resins with dielectric anisotropic mechanical properties, cosmetics and pharmaceutical compositions, diagnostics, liquid crystal pigments, for decorative and security purposes, in nonlinear optical materials, optical information storage media, or The use of chiral compounds and mixtures of formula (I) as chiral dopants and polymers obtained therefrom; And a mixture comprising at least one chiral compound of formula (I).

Подробнее
03-04-2020 дата публикации

一种环状化合物及其制备方法和应用

Номер: CN110950832A

本发明涉及一种式I所示的环状化合物及其制备方法和应用。本发明所述的环状化合物用于作为内给电子体化合物,可得到综合性能优良的烯烃聚合催化剂。特别是用于丙烯聚合时,催化剂的氢调敏感性好,所得聚合物的等规指数可调,所得聚丙烯树脂分子量分布宽。

Подробнее
28-08-2007 дата публикации

Acetal-based compositions

Номер: US7262236B2
Принадлежит: Milliken and Co

An acetal-based composition useful as a nucleating, gelling, thickening or clarifying agent is disclosed. The composition may be synthesized or provided in many different forms, including multicarbon diacetals formed from carbohydrates. Once synthesized, the compound may be employed as an additive in a plastic composition, such as (for example) a polypropylene copolymer. One structure of such an acetal-based composition is provided by the formula: wherein: n is 0, 1 or 2; Ar 1 and Ar 2 are independently selected from substituted or unsubstituted aryl-containing groups; and R is selected from the group consisting of: alkenyls, alkyls, alkoxy, hydroxyl alkyls, and alkyl-halides.

Подробнее
10-03-2009 дата публикации

Method of polyolefin composition nucleation by acetal compounds

Номер: RU2348637C2
Принадлежит: Милликен Энд Компани

FIELD: chemistry. SUBSTANCE: invention concerns method of polyolefin composition nucleation by mixing the composition with compound of the structural formula: , where: n is 0, 1 or 2; Ar 1 and Ar 2 are independently selected out of group including non-substituted aryl groups and aryl groups substituted by substitutes selected out of group including alkyl groups, alkenyl groups, alkinyl groups, alkoxy groups, carboxy groups and halogens; and R is selected out of group including alkenyl groups, alkyl groups, alkoxy groups, hydroxyalkyl groups and alkylhalide groups. Also invention claims the compound itself, method of its obtaining and moulded or cast polyolefin article including this compound. EFFECT: efficient method of polyolefin composition nucleation. 19 cl, 3 tbl, 22 ex ÐÎÑÑÈÉÑÊÀß ÔÅÄÅÐÀÖÈß RU (19) (11) 2 348 637 (13) C2 (51) ÌÏÊ C07D 493/04 (2006.01) C08K 5/1575 (2006.01) ÔÅÄÅÐÀËÜÍÀß ÑËÓÆÁÀ ÏÎ ÈÍÒÅËËÅÊÒÓÀËÜÍÎÉ ÑÎÁÑÒÂÅÍÍÎÑÒÈ, ÏÀÒÅÍÒÀÌ È ÒÎÂÀÐÍÛÌ ÇÍÀÊÀÌ (12) ÎÏÈÑÀÍÈÅ ÈÇÎÁÐÅÒÅÍÈß Ê ÏÀÒÅÍÒÓ (21), (22) Çà âêà: 2006141650/04, 05.04.2005 (24) Äàòà íà÷àëà îòñ÷åòà ñðîêà äåéñòâè ïàòåíòà: 05.04.2005 (30) Êîíâåíöèîííûé ïðèîðèòåò: 26.04.2004 US 10/831,920 16.07.2004 US 10/893,633 (43) Äàòà ïóáëèêàöèè çà âêè: 10.06.2008 (56) Ñïèñîê äîêóìåíòîâ, öèòèðîâàííûõ â îò÷åòå î ïîèñêå: US 597043 À, 26.10.1999. US 5049605 À, 17.09.1991. US 4314039 À, 02.02.1982. RU 2203898 Ñ2, 20.10.2000. (85) Äàòà ïåðåâîäà çà âêè PCT íà íàöèîíàëüíóþ ôàçó: 27.11.2006 2 3 4 8 6 3 7 R U (87) Ïóáëèêàöè PCT: WO 2005/111134 (24.11.2005) C 2 C 2 (86) Çà âêà PCT: US 2005/011686 (05.04.2005) Àäðåñ äë ïåðåïèñêè: 129090, Ìîñêâà, óë. Á.Ñïàññêà , 25, ñòð.3, ÎÎÎ "Þðèäè÷åñêà ôèðìà Ãîðîäèññêèé è Ïàðòíåðû", ïàò.ïîâ. Å.Å.Íàçèíîé (54) ÑÏÎÑÎÁ ÍÓÊËÅÀÖÈÈ ÏÎËÈÎËÅÔÈÍÎÂÎÉ ÊÎÌÏÎÇÈÖÈÈ ÀÖÅÒÀËÜÍÛÌÈ ÑÎÅÄÈÍÅÍÈßÌÈ (57) Ðåôåðàò: Äàííîå èçîáðåòåíèå îòíîñèòñ ê ñïîñîáó íóêëåàöèè ïîëèîëåôèíîâîé êîìïîçèöèè ïóòåì ñìåøåíè ýòîé êîìïîçèöèè ñ ñîåäèíåíèåì, èìåþùèì ñòðóêòóðó ôîðìóëû: ãäå: n ðàâíî 0, 1 èëè 2; Ar1 è Ar2 íåçàâèñèìî âûáðàíû èç ...

Подробнее
27-07-2006 дата публикации

1,2,4- Trioxepanes as precursors for lactones

Номер: US20060167281A1
Принадлежит: Akzo Nobel NV

The present invention pertains to a novel process for the preparation of lactones by decomposition of a 1,2,4-trioxepane of formula (I) wherein, R is H or CH 3 , n is 1-14, Rx independently is any substituent on the ring structure, including substituents which form bi- or tricyclic structures, and m is 0-34.

Подробнее
14-11-2013 дата публикации

Macrocyclic picolinamides as fungicides

Номер: WO2013169660A1
Принадлежит: DOW AGROSCIENCES LLC

The present disclosure relates to macrocyclic picolinamides and their use as fungicides. The compounds of the present disclosure may offer protection against ascomycetes, basidiomycetes, deuteromycetes and oomycetes. The present disclosure presents a method for the control or prevention of fungal attack on a plant, the method including the steps of applying a fungicidally effective amount of one or more of the compounds described to at least one of the fungus, the plant, and an area adjacent to the plant.

Подробнее
17-02-2005 дата публикации

1,2,4,-trioxepanes as precursors for lactones

Номер: WO2005014569A1
Принадлежит: AKZO NOBEL N.V.

The present invention pertains to a novel process for the preparation of lactones by decomposition of a 1,2,4-­trioxepane of formula (I) wherein, R is H or CH3, n is 1-14, Rx independently is any substituent on the ring structure, including substituents which form bi- or tricyclic structures, and m is 0-34.

Подробнее
31-05-2012 дата публикации

Inhibitors of the activity of complex iii of the mitochondrial electron transport chain and use thereof for treating diseases

Номер: WO2012070015A1
Принадлежит: STEMERGIE BIOTECHNOLOGY SA

The present invention relates to compounds which are inhibitors of the activity of Complex III of the mitochondrial electron transport chain and pharmaceutical compositions comprising said compounds alone or in combination with other active agents. The present invention further relates to use of the compounds of the invention as medicaments or as agrochemicals where their properties as inhibitors of the mitochondrial respiration is of benefit. More particularly the present invention relates to the use of the compounds of the invention in a method of treating and/or preventing cancers presenting tumor-initiating cells. (Formula I) (I)

Подробнее
01-11-2016 дата публикации

Synthesis and use of isotopically labeled macrocyclic compounds

Номер: US9482661B2
Принадлежит: DOW AGROSCIENCES LLC

Disclosed herein are isotopically labeled antifungal antibiotics and related compounds. Also disclosed are methods for synthesizing these isotopically labeled molecules and using the same to study the distribution of these compounds in the biosphere as well as the products formed by the breakdown of these isotopically labeled compounds.

Подробнее
13-07-2016 дата публикации

Use of macrocylic picolinamides as fungicides

Номер: CN105764897A
Принадлежит: DOW AGROSCIENCES LLC

本发明涉及式I的大环吡啶酰胺以及它们作为杀真菌剂的用途(结构表示的)。

Подробнее
24-01-2017 дата публикации

Macrocyclic picolinamides as fungicides

Номер: US9549556B2
Принадлежит: DOW AGROSCIENCES LLC

The invention relates to macrocyclic picolinamides of Formula I and their use as fungicides.

Подробнее
14-01-2016 дата публикации

Macrocyclic picolinamides as fungicides

Номер: WO2016007529A1
Принадлежит: DOW AGROSCIENCES LLC

This disclosure relates to macrocyclic picolinamides of Formula (I) described herein, wherein X, Y, R1 and R2 are as defined herein and to their use as fungicides in a formulation comprising a phytologically acceptable carrier. Also provided are methods of using compounds of Formula (I) in combination with other pesticides including fungicides, insecticides, nematocides, miticides, arthropodicides, bactericides, and combinations thereof.

Подробнее
16-07-2016 дата публикации

Macrocyclic picolinamides as fungicides

Номер: TW201625577A
Принадлежит: 陶氏農業科學公司

本發明係關於式I之巨環吡啶醯胺及其作為殺真菌劑之用途。 □

Подробнее
17-04-2018 дата публикации

macrocyclic picolinamide compounds with fungicidal activity.

Номер: BR112017013062A2
Принадлежит: DOW AGROSCIENCES LLC

a presente invenção refere-se a picolinamidas macrocíclicas de fór-mula (i) e seu uso como fungicidas. The present invention relates to macrocyclic picolinamides of formula (I) and their use as fungicides.

Подробнее
29-08-2017 дата публикации

Big ring picolinamide as fungicide purposes

Номер: CN107105662A
Принадлежит: DOW AGROSCIENCES LLC

本发明涉及式I的大环吡啶酰胺以及它们作为杀真菌剂的用途。

Подробнее
15-02-2007 дата публикации

Isolation, formulation, and shaping of macrocyclic oligoesters

Номер: US20070037464A1
Принадлежит: Cyclics Corp

Processes for isolating, formulating, and shaping macrocyclic oligoesters were developed which allow efficient production of macrocyclic oligoesters substantially free from solvent, which may include additives, fillers, and catalysts.

Подробнее
27-06-2016 дата публикации

MACROCYCLIC PICOLINAMIDES AS FUNGICIDES

Номер: RU2014149186A

1. Соединение формулы IR представляет собой H или C(O)R;Rпредставляет собой H, C(O)Rили Q;Q представляет собойRнезависимо представляет собой H, алкил, алкенил, арил, гетероциклил, каждый из которых замещен 0, 1 или несколькими R, или -C(O)R;Rнезависимо представляет собой H, алкил, или алкенил, каждый из которых замещен 0, 1 или несколькими R;Rнезависимо представляет собой алкил или алкокси, замещенные 0, 1 или несколькими R;Rпредставляет собой алкил, алкенил, галоген, галогеноалкил, алкокси, галогеналкокси, C(O)R, арилалкокси или арил;Rпредставляет собой алкокси или бензилокси;Rпредставляет собой H, -С(O)R, или -CHOC(O)R; иRпредставляет собой H, алкенил, галоген, галогеналкил, алкокси, галогеналкокси, арилалкокси или арил.2. Соединение по п. 1, где:R представляет собой H, C(O)R;Rпредставляет собой H, C(O)R;Rпредставляет собой независимо или отдельно H, алкил, алкенил, арил, каждый из которых замещен 0, 1 или несколькими R;Rнезависимо или отдельно представляет собой или H, метил;Rпредставляет собой алкил, алкокси, галоген, галогеналкил или арил; иRпредставляет собой алкокси, бензилокси.3. Соединение по п. 1, где:R представляет собой H;Rпредставляет собой Q, где Q представляет собойRнезависимо или отдельно представляет собой или алкил, арил, каждый из которых замещен 0, 1 или несколькими R;Rнезависимо или отдельно представляет собой или H, метил;Rпредставляет собой алкил, замещенный 0, 1, или несколькими R;Rпредставляет собой алкил, алкокси, галоген, галогеналкил или арил; иRпредставляет собой H, -C(O)R, -CHOC(O)R.4. Композиция для борьбы с патогенными грибами, содержащая по меньшей мере одно соединение по пп. 1-3 и фитологически приемлемый материал носителя.5. Композиция для борьбы с патогенными грибами, содержащая смеси по меньшей мере одного соединения по любому одному из пп. 1-3 с други РОССИЙСКАЯ ФЕДЕРАЦИЯ (19) RU (11) (51) МПК C07D 405/12 (13) 2014 149 186 A (2006.01) ФЕДЕРАЛЬНАЯ СЛУЖБА ПО ИНТЕЛЛЕКТУАЛЬНОЙ СОБСТВЕННОСТИ (12) ЗАЯВКА НА ИЗОБРЕТЕНИЕ (21)(22) Заявка ...

Подробнее
05-06-1990 дата публикации

Methods of using chemiluminescent 1,2-dioxetanes

Номер: US4931223A
Принадлежит: Tropix Inc

Processes are disclosed in which light of different wavelengths is simultaneously released from two or more enzymatically decomposable chemiluminescent 1,2-dioxetane compounds, said compounds being configured, by means of the inclusion of a different light emitting fluorophore in each of them, to each emit light of said different wavelengths, by decomposing each of said compounds by means of a different enzyme. Such processes can be used in multi-channel assays--immunoassays, chemical assays and nucleic acid probe assays--to detect the presence or determine the concentration of chemical or biological substances, and in multi-channel chemical/physical probe procedures for studying the microstructures of macromolecules.

Подробнее
10-03-2008 дата публикации

Azaheterocycles, combinatory library, focused library, pharmaceutical composition and method for preparing (variants)

Номер: RU2318818C1

FIELD: organic chemistry, medicine, biochemistry, pharmacy. SUBSTANCE: invention relates to novel azaheterocycles of the general formula (I): possessing inhibitory effect on activity of tyrosine kinase and can be used in treatment of different diseases mediated by these receptors. In compound of the general formula (1) W represents azaheterocycle comprising 6-13 atoms that can be optionally annelated with at least one (C 5 -C 7 )-carbocycle and/or possibly annelated with heterocycle comprising 4-10 atoms in ring and comprising at least one heteroatom chosen from oxygen (O), sulfur (S) or nitrogen (N) atom; R a   1 represents a substitute of amino group but not hydrogen atom, such as substituted (C 1 -C 6 )-alkyl, possibly substituted aryl and possibly substituted 5-10-membered heterocyclyl comprising at least one heteroatom chosen from O, S or N; R b represents carbamoyl group -C(O)NHR a wherein R a represents a substitute of amino group but not hydrogen atom, such as possibly substituted alkyl, possibly substituted aryl, possibly substituted 5-10-membered heterocyclyc comprising at least one heteroatom chosen from O, S or N; R c represents a substitute of cyclic system, such as possibly substituted (C 1 -C 6 )-alkyl, possibly substituted aryl and possibly substituted 5-6-membered heterocyclyl comprising at least one heteroatom chosen from O, S or N; or R b and R c form in common aminocyanomethylene group [(=C(NH 2 )CN], or their pharmaceutically acceptable salts. Also, invention relates to methods for synthesis of these compounds (variants), a pharmaceutical composition, combinatory and focused libraries. EFFECT: valuable medicinal properties of compounds and pharmaceutical composition, improved methods for synthesis and preparing. 35 cl, 16 sch, 13 tbl, 43 ex ÐÎÑÑÈÉÑÊÀß ÔÅÄÅÐÀÖÈß (19) RU (11) 2 318 818 (13) C1 (51) ÌÏÊ C07D C07D C07D C07D C07D C07D ÔÅÄÅÐÀËÜÍÀß ÑËÓÆÁÀ ÏÎ ÈÍÒÅËËÅÊÒÓÀËÜÍÎÉ ÑÎÁÑÒÂÅÍÍÎÑÒÈ,C07D ÏÀÒÅÍÒÀÌ È ÒÎÂÀÐÍÛÌ ÇÍÀÊÀÌ C07D C07D C07D 243/06 241/36 241 ...

Подробнее
17-11-2004 дата публикации

Isolation, formulation, and shaping of macrocyclic oligoesters

Номер: CN1547577A
Принадлежит: Cyclics Corp

本发明开发出了分离、配制和成型加工大环低聚酯的工艺,从而实现了基本无溶剂的大环低聚酯的高效生产,其中该大环低聚酯可以包括添加剂、填料和催化剂。

Подробнее
02-02-2016 дата публикации

Bromine-sensitized solar photolysis of carbon dioxide

Номер: US9249508B2
Автор: Mark S. Braiman
Принадлежит: Mark S. Braiman

There is described a process for depositing carbon on a surface, comprising, while contacting a mixture of CO 2 and Br 2 with a polar substrate presenting apposed surfaces, exposing a sufficient area of said mixture in the region of said apposed surfaces to light of sufficient intensity and frequency to result in deposition of carbon on at least some of said apposed surfaces. Other embodiments are also described.

Подробнее
03-05-2022 дата публикации

Cyclic micro-crosslinkable polycarboxylic acid polymerization intermediate, preparation method thereof and polycarboxylic acid water reducing agent

Номер: CN113336740B

本发明涉及混凝土外加剂技术领域,具体公开了一种环状可微交联聚羧酸聚合中间体的制备方法,包括以下步骤:将多元醇及有机溶剂加入反应器中,搅拌均匀后加入缚酸剂,通入氮气保护,在0~5℃条件下,滴加不饱和酰氯反应1~8h,用饱和盐溶液进行萃取得到萃取物,然后将萃取物减压蒸馏蒸发有机溶剂,得到环状可微交联聚羧酸聚合中间体。本发明利用多元醇与不饱和酰氯直接高效酯化得到环状可微交联聚羧酸聚合中间体,将制得中间体应用于羧酸聚合,得到带环状结构且分子链微交联的聚羧酸减水剂,降低羧酸对泥土的敏感性,提高聚羧酸减水剂的保水性,增强对水泥的分散能力,降低对水的敏感度,提高抗离析泌水性能。

Подробнее
01-04-2015 дата публикации

Low catalyst loading in metathesis reactions

Номер: CN104487409A
Автор: R·卡德罗夫
Принадлежит: 赢创工业集团股份有限公司

本发明涉及制备复分解产物的方法,其包括在复分解条件下使复分解起始物与复分解催化剂接触,其中,所述复分解催化剂的使用量为基于所述复分解起始物反应性双键总和的一半的0.0001-1摩尔%,并且其中,从反应混合物中除去在反应过程中产生的乙烯或丙烯。

Подробнее
04-08-1992 дата публикации

Propanamine derivatives

Номер: US5135955A
Принадлежит: Eli Lilly and Co

Substituted propanamines having anticoagulant or antifungal activity are disclosed. Also disclosed are methods of use involving the substituted propanamines as well as pharmaceutical compositions containing them.

Подробнее
01-09-2010 дата публикации

Liquid crystal display

Номер: EP1911828B1
Принадлежит: Merck Patent GmBH

Подробнее
16-04-2008 дата публикации

Liquid-crystal display

Номер: CN101162333A
Принадлежит: Merck Patent GmBH

本发明涉及PSA(聚合物支持的配向)型液晶显示器,和用于PSA显示器的新型液晶介质和新型可聚合化合物。

Подробнее